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GENERAL INTRODUCTION 
Explanation of Dissertation Format 
This dissertation has been written in the alternate format, in which the 
research data are presented in the form in which they were submitted for 
publication. Section I was published in March, 1991, in the journal Applied and 
Environmental Microbiology. Section II has been submitted for publication in 
the journal Applied and Environmental Microbiology. The general introduction 
states the objectives of the research and the review of the literature gives the 
reader background information on bacteriocins. The dissertation is summarized 
in the conclusions and prospectus which follow the papers. All data presented 
in this dissertation were collected by the primary author. 
Objective 
Bacteriocins, which are produced by a heterogenous group of 
microorganisms, have a wide range of chemical properties, modes of action, 
and antibacterial spectra. Properties of bacteriocins produced by gram-positive 
microorganisms frequently differ from those of gram-negative microrganisms. 
The properties of prototype bacteriocins made by gram-negative organisms were 
used as criteria for defining other bacteriocins. The prototype bacteriocins were 
encoded by plasmids and killed only microorganisms within the genus of the 
producer strain. These early criteria have been found not to be applicable to 
bacteriocins made by gram-positive microorganisms. Tlie gram-positive 
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bacteriocins are encoded either chromosomally or on plasmids and frequently 
exhibit a wide range of activity against both gram-negative and gram-positive 
genera. 
Consumers are demanding a new generation of foods characterized by 
minimal processing and removal of preservatives. This has renewed 
researchers' interest in finding natural antimicrobial agents such as bacteriocins. 
Given these demands, research into the genetics, biochemistry, and production 
of bacteriocins is needed to provide more information about these potential new 
preservatives. 
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LITERATURE REVIEW 
Introduction 
Bacteriocins are antibacterial substances produced by a diverse number of 
bacterial species. Bacteriocins produced by this heterogeneous group have 
different chemical properties, modes of action, and antibacterial spectra. Tagg et 
al. (1976) defined bacteriocins as protein-containing molecules that exert a 
bactericidal mode of action on susceptible bacteria. Other criteria for defining 
bacteriocins are specific bacteriocin receptors on sensitive bacteria, plasmid-
bome determinants of production and immunity, and a narrow range of 
inhibitory activity, usually confined to homologous species. 
Until recent years, investigations in the field of bacteriocins have been 
centered on gram-negative bacteria. The best understood group of gram-
negative bacteriocins is the colicins produced by Escherichia coli. These 
colicins have been well characterized as to their mode of action, host range, 
genetic determinants, purification, and ecological function. 
The above criteria are generally applicable to the prototype bacteriocins, 
such as the colicins; however, a number of gram-positive microorganisms 
produce bacteriocins that deviate from the original definition of bacteriocins 
(Tagg et ai, 1976). Atypical characteristics associated with gram-positive 
bacteriocins include a wider spectmm of activity against organisms of different 
genera and species, and nonspecific bacteriocin receptors (Al-Zoreky, 1988; 
Daeschel et al., 1988; Gonzales and Kunka, 1987). 
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Consumers are demanding a new generation of foods characterized by 
minimal processing and the removal of preservatives. This has renewed 
researchers' interest in finding natural antimicrobial agents such as bacteriocins, 
some of which (e.g. nisin and Microgard) have already obtained FDA approval 
for use in foods (Al-Zoreky, 1988; Weber and Broich, 1986). Given these 
demands, research into the genetics, biochemistry, and production of 
bacteriocins is needed to provide more information about these potential new 
preservatives. 
Nomenclature and Classification of Bacteriocins 
For many years, the naming of bacteriocins has lacked uniformity. For 
example, bacteriocins from Listeria monocytogenes have been named either 
listeriocins (Tubylewicz, 1963) or monocins (Hamon and Peron, 1966), those 
of Staphylococcus aureus as either staphylococcins (Fredericq, 1948) or 
aureocins (Moore, 1970), and those of Corynebacterium diphtheriae as corycins 
(Krylova, 1969) or diphthericins (Gibson and Coleman, 1973). 
Because of this early confusion, it has been recommended that bacteriocins 
be named by the genus of the producing microorganism (Tagg et ai, 1976). 
When more than one bacteriocin is produced by a single microorganism, 
additional designations are required for differentiation, e.g. consecutive letters 
of the alphabet are added to the name of the bacteriocin. For example, group A 
Streptococcus strain FF22 produces a bacteriocin designated as streptococcin 
A-FF22 (Tagg et al., 1973). 
5  
Bacteriocins of Various Gram-positive Genera 
Bacillus. Many strains of Bacillus have been shown to produce antibiotic 
substances, only some of which have been characterized in detail. Bacillus 
species that have been reported to produce bacteriocin-like inhibitors are B. 
stearothermophilus (Shafia, 1966), B. licheniformis (Bradley, 1967), 5. 
thuringiensis (de Barjal and Lajudie, 1974), and B. subtilis (Bradley, 1967). 
Bradley (1967) found that 5. subtilis and B. licheniformis produce 
bacteriocins that are actually defective phages. Megacin, produced by B. 
megaterium, was characterized as a protein with a narrow range of activity and 
was established to be phospholipase A (Ozaki et al., 1966; Ochi et al., 1970). 
Carnobacterium. Heterofermentative strains of nonaciduric lactobacilli have 
been classified in a new genus, Carnobacterium, based on their phenotypic 
characteristics (Collins etal., 1987). Carnobacterium piscicola LV17 isolated 
from vacuum-packed meat produces bacteriocins that are active against closely 
related lactobacilli, enterococci, and one strain of Listeria monocytogenes (Ahn 
and Stiles, 1990). Production of bacteriocin and immunity proteins was found 
to be associated with two plasmids with molecular weights 40 and 49 
megadaltons. The plasmids were found to encode different bacteriocins because 
the inhibitory substances produced by mutant strains containing single plasmids 
had different antimicrobial spectra. 
Clostridium. Boticin P-PM15, produced by Clostridium botulinum, has 
been shown to be a heat-labile, trypsin-sensitive, defective phage (Lau, 1974). 
Kautter et al. (1966) found boticin E-S5, also produced by C. botulinum, to be 
dialyzable and stable to heat. It was later shown that strain E-S5 produced two 
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distinct boticins, with molecular weights greater than 4 x 10^ and less than 3 x 
104 (Ellison and Kautter, 1970). 
Sasarman and Antohi (1963) found four strains of Clostridium perfringens 
that produced different bacteriocins, each with different activity spectra. 
Mahonyefa/. (1971) studied one of the bacteriocins of in some 
detail and reported its mode of action to be bacteriostatic. 
Lactohacillus. Lactobacilli have been shown to produce antibacterial 
substances that are unrelated to bacteriocins. These include hydrogen peroxide 
(Wheater et al, 1952), lactic acid (Tramer, 1966), and a broad-spectrum 
antibiotic called lactocidin (Vincent et a/., 1959). 
Both homofermentative and heterofermentative lactobacilli have been found 
to release bacteriocins (Axelsson et al, 1988; DeKlerk, 1967). DeKlerk and 
Smit (1967) characterized bacteriocin-like substances in lactobacilli. 
Bacteriocins produced by L.fermentii (DeKlerk and Smit, 1967) and L. 
helveticus LP27 (Upreti and Hindsdill, 1973) were purified and characterized 
as Hpopolysaccharide-protein complexes composed of several subunits. Of 
these two bacteriocins, only that produced by LP27 was able to retain activity 
when dissociated into its subunits. 
More recently. Barefoot and Klaenhammer (1983) described a bacteriocin in 
Lactobacillus acidophilus, named lactacin B, which is a large, heat-stable protein 
with a molecular weight of approximately 100,000. These investigators found 
that the lactacin B activity was bactericidal but not bacteriolytic. Furthermore, 
the production of lactacin B was pH-dependent, with maximum activity at pH 
6.0 (Barefoot and Klaenhammer, 1984). Lactacin B could be dissociated into 
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subunits of molecular weight 6,000 - 6,500 in the presence of 8 M urea and 
0.1% sodium dodecyl sulfate (Barefoot and Klaenhammer, 1984). 
Lactacin F (MW 25,000), a bacteriocin produced by Lactobacillus 
acidophilus 11088, was purified and characterized by Muriana and 
Klaenhammer (1991). Lactacin F was found to be heat-stable, proteinaceous, 
and inhibitory against other lactobacilli as well as against Enterococcusfaecalis. 
Lactacin F samples obtained by gel filtration appeared to be globular, micelle­
like particles when observed by electron microscopy. It was suggested that 
these structures were large macromolecular bacteriocin complexes. Under 
nondenaturing conditions, these particles were sized at approximately 180 KDa 
by gel filtration chromatography (Muriana and Klaenhammer, 1991). 
Amino acid sequence analysis of purified lactacin F identified 56 residues of 
which 16 were hydrophobic and located near the N-terminus (Kortel et al, 
1989). These investigators suggested that many antimicrobial peptides (nisin, 
subtilin, lactacin S, and lactacin F) contain a region of hydrophobicity which 
enables the bacteriocin to interact with the cell membrane (Kortel et al., 1989; 
Mortvedt et al, 1991; Schuller et al., 1989). Nisin (Kortel et al., 1989) and 
subtilin (Schuller et al., 1989) have been shown to cause their bactericidal effect 
channel formation in cell membranes. Muriana and Klaenhammer (1991) found 
that lactacin F inhibited protoplasts of Enterococcusfaecalis OGIX and 
Lactobacillus acidophilus NCK88, whereas whole cells were unaffected. They 
suggested that the immunity functions of L. acidophilus NCK88 and E.faecalis 
to lactacin F reside within the cell wall. They further speculated that lactacin F 
may act as a surfactant, removing the cell walls of sensitive cells, thereby 
disrupting cellular functions. 
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Lactocin S, a bacteriocin produced by Lactobacillus sake L45, has been 
purified to homogeneity by ion exchange, hydrophobic interaction, and gel 
filtration chromatography (Mortvedt et ai, 1991). Earlier work by Mortvedt 
and Nes (1989) indicated that a crude preparation of lactocin S eluted by gel 
filtration had an apparent molecular weight of 30,000, but the purified 
bacteriocin eluted during subsequent purification steps had a molecular weight 
of less than 13,700 (Mortvedt et al., 1991). These investigators speculated that 
the discrepancy in molecular weights was due either to the association of the 
bacteriocin with macromolecules in the crude preparation or to the formation of 
dimeric or trimeric forms of the bacteriocin. 
The amino acid composition of purified lactocin S was determined by 
Edman degradation by using an automatic sequence analyzer, and was found to 
be 33 amino acids, of which 50% were the nonpolar amino acids alanine, 
valine, and leucine (Mortvedt et al., 1991). The primary amino acid 
composition of lactocin S was compared to that of other bacterial proteins. 
Mortvedt et a/. (1991) suggested that the target site for mode of action of 
lactocin S is the cell membrane because of its hydrophobicity and the presence 
of a signal sequence that is homologous with those of pectate lyase B precursor 
(Lei et al., 1987) and the bacteriorhodopsin precursor (Katre et al., 1981) that 
are known to be embedded in the cell membrane. 
Lactobacillus helveticus 481 produces an antimicrobial agent active against 
closely related species (Joerger and Klaenhammer, 1986). Production of 
helveticin J was maximized in an anaerobic fermentor with pH controlled at 5.5. 
Helveticin J was found to be an aggregate having a molecular weight greater 
than 30,000. 
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Plantacin B, a bacteriocin produced by Lactobacillus plantarum NCDO 
1193, was reported to have inhibitory activity against several strains of 
lactobacilli and Clostridia (West and Warner, 1988). Strains of L. plantarum are 
important organisms in the production of silage and are presently used in 
commercial silage inoculants (West and Warner, 1988). Imperial Chemical 
Incorporated (ICI; Cleveland, England) is marketing Ecosyl, a silage inoculant 
containing L. plantarum 1193. 
Lactobacillus reuterii, a heterofermentative species, produces a low-
molecular weight, nonproteinaceous bacteriocin called reuterin (Axelsson et al., 
1988). Reuterin is a broad-spectrum antimicrobial agent that inhibits certain 
gram-negative and gram-positive bacteria, yeast, fungi, and protozoa. 
Pathogens that are inhibited by reuterin include species of Salmonella, Shigella, 
Clostridium, Staphylococcus, Listeria, Candida, and Trypanosoma. The 
efficacy of reuterin as a microbial inhibitor in ground beef has been examined; it 
may have application in the preservation of human and animal food (Axelsson et 
al., 1988). 
Pediococcus. A number of strains of pediococci are known to produce 
bacteriocins (Daeschel and Klaenhammer, 1985; Graham and McKay, 1985; 
Neilsen et al. 1990; Pucci et al., 1988; Spelhaug and Harlander, 1989). 
Commercially, pediococci are important in the fermentation of vegetables and 
meats (Pederson, 1949; Smith and Palumbo, 1983). The pediococci that are 
used as starter cultures in vegetable and meat fermentations have been 
investigated with regard to their bacteriocin-producing ability. Bacteriocins have 
been identified and characterized from Pediococcus acidilactici (Gonzales and 
Kunka, 1987; Hoover et al., 1988; Ray et al., 1988) and P. pentosaceus 
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(Daeschel and Klaenhammer, 1985; Graham and McKay, 1985). Pediocins are 
commonly encoded by genes found on plasmids and are active against a broad 
spectrum of gram-positive organisms. The importance of these bacteriocins lies 
in their ability to inhibit many food-bome pathogens, including Listeria 
monocytogenes (Daeschel eM/., 1988; Hoover era/., 1988; Ray era/., 1988). 
Therefore, these bacteriocins are becoming attractive antimicrobial additives for 
food preservation. 
Production of a bacteriocin designated as pediocin PA-1 by a strain of 
Pediococcus acidilactici was found to be associated with a 6.2 -megadalton 
plasmid (Gonzales and Kunka, 1987). Pediocin PA-1 showed activity against 
related species, while pediocin A, produced by a strain of Pediococcus 
pentosaceus, was inhibitory against every gram-positive organism tested 
(Daeschel and Klaenhammer, 1988). 
Staphylococcus. Staphylococci are known to produce a wide variety of 
inhibitory substances. Jetten and Vogels (1973 a, b) examined antagonistic 
substances produced by S. aureus and found several staphylococcins. Several 
low-molecular weight staphylococcins were referred to as antibiotics (Hsu and 
Wiseman, 1971; Jones and Edwards, 1966), although the distinction between 
low-molecular weight antibiotics and bacteriocins still remains unclear in several 
genera (Tagg et al., 1976). Other antimicrobial substances produced by 
staphylococci have been categorized as true bacteriocins. These include 
aureocin (Moore, 1970), staphylococcin 462 (Hale and Hindsdill, 1973), 
staphylococcin 414 (Gagliano and Hindsdill, 1970), and staphylococcin E55 
(Dajani and Wannamaker, 1969). 
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A crude preparation of staphylococcin 1261 from S. aureus was studied by 
Lachowicz and Walczak (1966). The activity was eluted in two peaks from both 
Sephadex G-50 and G-75 columns. The estimated molecular weights of these 
proteins were 30,000 and 9,700, respectively. The authors concluded that the 
larger protein might be a trimer of the other. Staphylococcin 1580, which is 
produced by Staphylococcus epidermidis 1580, is active against many gram-
positive but not gram-negative bacteria (Jetten and Vogels, 1972). This 
bacteriocin (MW 20,000) was purified by ammonium sulfate precipitation and 
gel filtration chromatography. 
Streptococcus. Brock et al. (1963) have described several bacteriocins 
produced by group D streptococci. The bacteriocin produced by S.faecalis 
subsp. zymogenes was shown to be identical to the hemolysin produced by this 
strain. In contrast, Bottone et al. (1971) isolated a bacteriocin from one strain of 
S.faecalis subsp. that was a true bacteriocin. 
The bacteriocins nisin and diplococcin from the group N streptococci have 
been well characterized. Klaenhammer (1988) has reviewed the genetics of 
nisin, diplococcin, and several other bacteriocins. Nisin, derived from "group 
N inhibitory substances," has been used as a food preservation agent in Swiss 
cheese (Hirsch et al., 1951), in which it prevented the "gassing" that occurs 
with growth of Clostridium within the cheese. The use of nisin as a 
preservative was further investigated with a large variety of fresh and processed 
foods including tomato juice (Campbell et al., 1959) and meat (Ogden, 1986). 
Nisin's antibacterial spectrum includes certain gram-positive organisms but not 
gram-negative bacteria, yeasts, or fungi. Recent investigators (Daeschel et al., 
1988; Doyle, 1988; Mohammed et ai, 1984) have shown that nisin and other 
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streptococcal bacteriocins are inhibitory toward Listeria monocytogenes, a food-
borne pathogen of major concern in the dairy industry. 
In streptococci, streptococcin A-FF22 (Florey et aL, 1949) and diplococcin 
(Mattick and Hirsch, 1944) have been studied extensively. Streptococcin A-
FF22 is similar to the bacteriocin nisin in molecular weight (approximately 
8,800), and activity spectrum (Cheeseman and Berridge, 1959; Gowan et al., 
1952). 
Alpha-hemolytic streptococci that have been shown to produce inhibitory 
substances include S. pneumoniae (Florey et al., 1949), S. mutans (Hamada 
and Ooshima, 1975), and oral streptococci (Kelstrup and Gibbon, 1969). 
Dajani et al. (1976) isolated bacteriocins from S. sanguis and S. mitis strains. 
These bacteriocins (termed vividens) exhibited a broad spectrum of activity 
including inhibition of both gram-negative and gram-positive organisms. 
Propionihacterium. Propionibacterium acnes CN8 produces a bacteriocin 
designated acnecin. Acnecin was found to be composed of five subunits each of 
molecular weight 12,000. Acnecin was reported to contain predominantly 
aspartic acid, glutamic acid, and alanine, but no cysteine (Fujimura and 
Nakamura, 1978). Acnecin activity was completely lost after heating at 600C 
for 10 minutes. Its activity was reduced by 50% upon storage at -20^0 for a 
month. Treatment with pronase, trypsin, and papain caused complete 
inactivation. Acnecin exhibited a narrow range of inhibitory activity, affecting 
only closely related strains of P. acnes and one strain of Corynebacterium 
parvum. 
Paul and Booth (1988) isolated a cell-associated bacteriocin-like substance 
with approximate molecular weight 78,000 from a strain of Propionibacterium 
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acnes. Several physical parameters of this substance were studied. 
Antimicrobial activity was stable at pH 7.0, but was lost below pH 2.0 or above 
pH 11.0. Activity was also lost after one hour incubation at 550C. This 
substance was reported to have a wide spectrum of activity against both gram-
positive and gram-negative organisms. In this regard it differs from acnecin 
CN-8 which has a relatively narrow host range. 
Microgard (Wesman Foods, Inc; Beaverton, OR) is a grade A skim milk 
product fermented by Propionibacterium shermanii and then pasteurized (Weber 
and Broich, 1986). Preliminary studies (Salih, 1985; Weber and Broich, 1986) 
demonstrated that Microgard prolongs the shelf life of cottage cheese by 
inhibiting psychrotrophic spoilage bacteria. Microgard has been approved by 
the U. S. Food and Drug Administration for use in cottage cheese. Weber and 
Broich (1986) estimated that 30% of the cottage cheese produced in the United 
States has Microgard added. The antagonistic spectrum of Microgard includes 
most gram-negative bacteria, some yeasts, and some molds, but not gram-
positive bacteria (Al-Zorecky, 1988). Al-Zorecky (1988) found propionic acid, 
diacetyl, acetic acid, and lactic acid in Microgard as well as a bacteriocin. This 
bacteriocin was found to be a 700-dalton heat-stable protein. Al-Zorecky 
postulated that the additive inhibitory effect of the organic acids and the 
bacteriocin contributed to the overall preservative qualities of Microgard. 
Methods of Demonstrating Antagonism 
The general test for antagonism is performed on solid medium and involves 
the inhibition of growth of an indicator strain. Two basic methods are used in 
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the detection of bacteriocins. These are referred to as the direct and the indirect 
methods. 
In the direct method, the test and indicator organisms are grown 
simultaneously and demonstration of antagonism is dependent upon the release 
of a diffusible inhibitor (Gratia, 1946; Kekessy and Piguet, 1970). The entire 
agar plate is inoculated with the indicator organism, and the test strain is spotted 
onto the indicator lawn. Several variations of this procedure have been tried, 
including the following: (1) overlapping drops or streaks of indicator and test 
strains (Barrow, 1963; Rosebury et al., 1954); (2) stabbing test strains into an 
agar containing the indicator organism (Barrow, 1963; De Klerk, 1967); (3) 
cutting wells into freshly seeded pour plate cultures and filling the weUs with 
agar containing the test organism (Sabine, 1963). 
Indirect methods of deferred antagonism were largely developed by 
Fredericq (1957); these methods were modified by others for detection of 
bacteriocins (Abbott and Shannon, 1958; Tagg and McGiven, 1971). In 
deferred antagonism, the test strain is grown on agar for a specified period and 
the bacteria are then killed by exposure to chloroform. Kekessy and Piguet 
(1970) described a useful technique that dispenses with the killing of the 
producer inoculum with chloroform. Five microliters of the producer strain are 
inoculated onto the surface of the agar. After growth, the agar slab is aseptically 
detached from the dish and allowed to fall into the lid with the inoculated surface 
down. With this technique, the agar separates the producer from the indicator 
strain. The plate is then overlaid with soft agar containing the indicator strain 
(Kekessy and Piguet, 1970). This method is advantageous because it allows the 
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investigator to discern between nondiffusing bacteriophage and diffusing 
bacteriocins. 
All assays for bacteriocin activity are based upon the demonstration of 
antagonistic activity, in which titer of a bacteriocin preparation is determined by 
serial two-fold dilutions. The reciprocal of the highest dilution causing 
inhibition of the indicator organism determines the number of arbitrary units 
(AU/ml) of bacteriocin activity. The simplest and most readily used assay is the 
critical dilution spot test (Mayr-Harting et al, 1972). In this test, serial two-fold 
dilutions of bacteriocin are spotted onto lawns of indicator cells until a loss of 
inhibitory activity is observed. Alternatively, the effect of bacteriocin on the 
viability and integrity of the indicator organism can be observed (Mayr-Harting 
et al., 1972). In this case, increasing amounts of bacteriocin preparation are 
added to a constant number of indicator cells. Cell lysis is followed by 
measuring the optical density of the test strain suspension. After a specified 
incubation time, the cell suspension is then plated out to determine the reduction 
in viability of the indicator organism. 
Antagonism that is Unrelated to Bacteriocin Production 
It has long been known that microorganisms are capable of producing 
inhibitory substances other than organic acids (lactic, acetic, and propionic) that 
are antagonistic toward microorganisms (Barefoot and Klaenhammer, 1984; 
Gonzales and Kunka, 1987; Harris et ai, 1989). Some additional inhibitors 
produced in various amounts include hydrogen peroxide (Banks et al., 1986), 
ammonia (Rogul and Carr, 1972), diacetyl, catalase, and lipase. 
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Many microorganisms (e.g., lactobacilli) generate hydrogen peroxide, 
whose antimicrobial activity has been well documented (Wheater et al., 1952). 
The production and accumulation of hydrogen peroxide in the growth medium 
with subsequent antagonistic effects has been demonstrated in Staphylococcus 
aureus (Dahiya and Speck, 1968), Pseudomonas species (Price and Lee, 
1970), and many other microorganisms (Holmberg and Hallander, 1972; MaUce 
etal., 1974). 
Diacetyl (2,3-butanedione) is a metabolic end product synthesized from 
pyruvate and produced by many lactic acid bacteria (Kandler, 1983). Jay 
(1982) demonstrated that diacetyl was inhibitory towards yeast, gram-negative 
bacteria, and gram-positive organisms. 
When investigating potential bacteriocin activity, it is important to eliminate 
unrelated substances that may mimic bacteriocin-like activity. As a starting 
point, lysogeny of a bacteriophage must be dissociated from actual bacteriocin 
activity (Hamon and Peron, 1968; Smith, 1974 ). There are several 
characteristics that differentiate bacteriocins from bacteriophage. Bacteriocins, 
unlike bacteriophage, do not carry the genetic information necessary for self-
replication; thus, only bacteriophage can be propagated on indicator strains. A 
potential problem can arise when an organism has both a bacteriocin and a 
bacteriophage. These two phenomena can be differentiated by using the 
reverse-side agar technique, in which bacteriocins can diffuse into the agar 
where as bacteriophages are nondiffusible (Kekessy and Piguet, 1970). 
Hamon and Peron (1968) have described several criteria that can be used in 
differentiating bacteriophage from bacteriocins: (1) bacteriocins are not affected 
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by large doses of ultraviolet radiation, and (2) bacteriocins are usually resistant 
to extreme heat (i.e., lOQOC - 1210C). 
Properties of Bacteriocins 
Most of the bacteriocins characterized to date contain a protein component 
that is required for activity (Barefoot and Klaenhammer, 1984; Dajani etal., 
1970; Joerger and Klaenhammer, 1986). Sensitivities to specific enzymes 
(proteases, lipases, etc.) are often used to identify important chemical moieties 
of the bacteriocin molecules. For example, bacteriocins produced by 
Lactobacillus fermenta 466 (De Klerk and Smit, 1967) and staphylococcin 
1580 (Jetten et al., 1972) have been shown to be lipopolysaccharide-protein 
complexes. 
Bradley (1967) has classified bacteriocins into two groups, designated as 
low- and high-molecular weight forms. Low-molecular weight bacteriocins are 
less sensitive to heat inactivation than are high-molecular weight forms. High-
molecular weight forms are likely to be phage-related, whereas the low-
molecular weight forms are not. Electron microscopy has revealed the presence 
of phage-like stmctures in high-molecular weight bacteriocin preparations. 
These phage-like structures resemble bacteriocins in that they are unable to 
propagate within cells susceptible to their killing action. However, unlike 
bacteriocins, their production is often inducible by ultraviolet irradiation or 
mitomycin C exposure (Garro and Marmur, 1970). Gram-positive organisms 
shown to produce bacteriocins that are morphologically similar to phage-like 
components include Clostridium botulinum (Inoue and lida, 1968), 
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Mycobacterium tuberculosis (Imaeda and Rieber, 1968), Listeria 
monocytogenes (Bradley and Dewar, 1966), Propionibacterium freudenreichii 
subsp. (Razafindrajaona, 1989), and various species 
(Bradley, 1965; Okamoto et al., 1968). Tagg et al. (1976) have suggested that 
all defective bacteriophages should be excluded from the bacteriocin category, 
but for completeness they have been included in this review. 
A common characteristic of gram-positive bacteriocins is the existence of 
multimeric forms. Aggregation of the bacteriocin can be influenced by pH, 
ionic strength of the preparation, and treatment with 6 M urea or 0.1% sodium 
dodecyl sulfate (Jetten et al., 1972; Schlegal and Slade, 1974). Monomeric 
forms of streptococcin B-74628 (Tagg et al., 1975), staphylococcin 462 (Hale 
and Hindsdill, 1973), and lactocin LP27 (Upreti and Hiridsdill, 1973) all have 
molecular weights in the range of 8,000 to 12,000, while the multimeric forms 
range in molecular weight from 9,000 to 100,000. Barefoot and Klaenhammer 
(1984) found that a cmde preparation of lactacin B contained a protein 
aggregrate with the molecular weight of 100,000. When subjected to protein-
denaturing agents (8 M urea), an active monomeric form having a molecular 
weight 6,000 was isolated. 
Production of Bacteriocins 
Composition of the growth medium. In a number of gram-positive 
organisms, production of bacteriocin or bacteriocin-like substances has been 
dependent on a solid medium (Barefoot and Klaenhammer, 1983; Bottone et 
al., 1971; Gagliano and Hinsdill, 1970; Paul and Booth, 1988). Kelstrup and 
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Gibbons (1969) found that changing the viscosity of liquid media by addition 
of dextran, glycerol, starch, or agar increased the yield of bacteriocin produced 
by streptococci. Similarly, staphylococcin yields were increased by the use of 
semisolid media (Jetten et al., 1972; Jetten and Vogels, 1974). 
The addition of particular medium components was found to be necessary 
for the production of some bacteriocins. The production of bacteriocin by S. 
mutans was enhanced by the addition of 2% (w/v) yeast extract to a basal 
trypticase medium (Rogers, 1972). The formation of butyricin was dependent 
on the amount of casein hydrolysate added to a semidefined medium (Clarke et 
al., 1975). The presence of glucose in the medium increased the production of 
streptococcin A-FF22, but reduced the production of streptococcin B-7468 
(Tagg et al., 1973). 
Conditions of incubation. Variation in culture conditions and physical 
parameters such as temperature, aeration, and pH have been shown to affect 
yields of bacteriocin. As a rule, the production of bacteriocin is found to be 
maximum at the optimal temperature for growth of the producer strain (Dajani 
and Taube, 1974). Several investigators have demonstrated that bacteriocin 
production can be optimized by small shifts in the pH of the medium (Barefoot 
and Klaenhammer, 1984; Goebel et al., 1955). The production of helveticin J 
at pH 5.5 was 6,400 AU/ml, but at pH 6.0 and pH 7.0, the activities were 
3,200 AU/ml and 800 AU/ml, respectively. 
Optimal production of bacteriocin can occur at different growth phases in 
different microbial species. Schlegel and Slade (1972,1974) found that 
production of streptocin STH was optimal during exponential phase, while 
streptococcin A-FF22 production did not occur until stationary phase. 
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Similarly, production of staphylococcin C55 started during logarithmic phase 
and reached maximum production between 24 and 48 hours of incubation 
(Dajani and Wannamaker, 1969). 
Several investigators have reported that some strains of bacteria release 
bacteriocin continuously, whereas others produce it in short bursts (Barefoot 
and Klaenhammer, 1983; Joerger and Klaenhammer, 1986; Lachowicz and 
Brodzicki, 1973). Lachowicz and Brodzicki (1973) found that the production 
of staphylococcin A-1262a was first detected at hour 8, reached a maximum at 
hour 18, and subsequently dropped to zero after 24 hours. The loss of 
bacteriocin activity may have been due to the appearance of specific bacteriocin 
inactivators or proteolytic enzymes, or could be attributed to reabsorption of the 
bacteriocin into the producer cells (Dajani and Wannamaker, 1969; Gonzales 
and Kunka, 1987). 
Inducibility of Bacteriocins 
Production of bacteriocin in some gram-positive microorganisms has been 
shown to be inducible in a manner similar to prophage induction (Adam, 1959). 
Many of the inducible substances have been shown to be structurally related to 
bacteriophages, and it has been suggested that these are defective phages rather 
than bacteriocins (Garro and Marmur, 1970; Reeves, 1972). Bacillus 
megaterium (Ivanovics and Nagy, \95%), Listeria monocytogenes (Hamon and 
Peron, 1961), and Propionibacteriumfreudenreichii subsp. shermanii 
(Razafindrajaona, 1989) have been found to produce defective bacteriophages 
after irradiation or mitomycin C exposure. However, not all bacteriocins are 
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inducible. In some bacteria, the production of bacteriocin may be elevated 
substantially by UV irradiation or mitomycin C exposure (Clarke et al., 1975; 
Tubylewicz, 1963), while in other bacteria the yield seems to be reduced (Dajani 
et al., 1970; Hongo et al., 1968) or unchanged by this treatment (Paul and 
Booth, 1988). 
Treatments with ultraviolet irradiation or mitomycin C are the methods most 
often used for bacteriocin induction. Other techniques that have been used for 
induction include the use of novobiocin (Graham and McKay, 1985) and 
elevated temperature (Gonzales and Kunka, 1987). 
Production of Bacteriocin Inhibitors and Inactivators 
Davie and Brock (1966) demonstrated that teichoic acid found in the cell 
membrane functioned as a receptor for bacteriocin binding in Streptococcus 
faecalis subsp. zymogenes. Strains resistant to this bacteriocin produced a 
specific inhibitor that subsequently bound to the teichoic acid receptor and 
blocked the binding of the bacteriocin. Excretion of this inhibitor during the 
latter stages of the growth cycle resulted in the disappearance of bacteriocin from 
the culture medium. 
In studies with Staphylococcus epidermidis, the activity of staphylococcin 
1580 was increased by performing dialysis on the culture supernatant (Jetten et 
al., 1972). The authors hypothesized that the inhibitor passed into the dialysate, 
which suggested it was a low-molecular-weight compound. 
Proteases produced during the late stages of growth by bacteriocinogenic 
microorganisms may inactivate the bacteriocin. Some investigators have shown 
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that boiling bacteriocin preparations will inactivate these proteases, and thereby 
protect any heat-stable bacteriocins from digestion (Ellison and Kautter, 1970). 
But caution should be exercised; helveticin J, a bacteriocin from Lactobacillus 
helveticus 481, was found to be inactivated by both proteolytic enzymes and 
heat (Joerger and Klaenhammer, 1986). 
Location and Purification of Bacteriocin 
The production of bacteriocins by many of the gram-positive bacteria 
frequently seems not to be inducible or yields low titers of activity in the culture 
supernatant. Therefore, large batches of culture medium are needed for 
purification purposes. Furthermore, production of some bacteriocins requires 
solid medium. Recovery of bacteriocin from the agar may be accomplished by a 
freeze-thaw elution technique (Jetten et al., 1972; Tagg et ai, 1973). The 
producer strain is inoculated onto the entire surface of the agar, incubated for a 
specified time, and the plates are then frozen at -20OC for 4 hours. The plates 
are thawed at 370C, and the liquid from the collapsed agar collected and 
centrifuged. The liquid containing the bacteriocin is then evaluated for activity 
by a critical dilution assay. 
Many of the bacteriocins of gram-positive microorganisms exist in both cell-
associated and extracellular fomis. Bacteriocins that are cell-bound can be 
released from the cell by physical, chemical, or enzymatic methods. Ultrasonic 
treatment of the cells was effective in releasing bacteriocins from 
Propionibacterium acnes (Fujimura and Nakamura, 1978) and Staphylococcus 
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aureus (Gagliano and Hindsdill, 1970). In contrast, staphylococcin 462 (Hale 
and Hindsdill, 1973) could not be released by sonication. 
Bacteriocins have been eluted from the cell membrane with 7 M urea or 1 M 
sodium chloride (Foulds, 1972). Streptococcal bacteriocins nisin (White and 
Hurst, 1968) and diplococcin (Oxford, 1944) were obtained by extraction with 
dilute acid. Heat treatment was used to extract lactocin LP27 from 
homofermentative lactobacilli (Upreti and Hindsdill, 1973). Donoghue (1972) 
found that megacin C-216 was released from producing cells of B. megaterium 
by trypsin pretreatment followed by lysozyme treatment. Homma and Suzuki 
(1964) used lysozyme and EDTA, at concentrations of 150 mg/ml and 5 x 10"3 
M, respectively, to lyse Pseudomonas aeruginosa and extract the bacteriocin. 
After crude bacteriocin is obtained in a soluble, cell-free form, purification 
begins with separation of the bacteriocin from other cell components, metabolic 
products, and medium constituents. The methods of bacteriocin purification are 
basically those of protein biochemistry, and a wide variety of techniques has 
been used with varying success. Initial purification usually requires ammonium 
sulfate precipitation of the crude bacteriocin extract. The protein precipitate is 
removed from the ammonium sulfate solution by centrifugation, and the 
resulting pellet is then resuspended in a buffer and dialyzed against the same 
buffer. Subsequent purification may be based on separation according to 
molecular weight differences by gel chromatography, ultrafiltration, or 
centrifugation techniques. Bacteriocin activity is monitored throughout the 
purification process, and protein concentrations are determined by measuring the 
absorbance at 260 nm or by colorimetric methods. 
2 4  
The stabiUty of bacteriocin preparations has been reported to decrease with 
increased purification (Barefoot and Klaenhammer, 1984). These investigators 
suggested that the addition of bovine serum albumin may protect purified 
bacteriocins from loss of activity. 
Genetic Determinants of Bacteriocins 
The majority of bacteriocin detemiinants, in both gram-positive and gram-
negative bacteria, are found on plasmids. Spontaneous loss of the plasmids 
causes an irreversible loss of bacteriocinogenicity. The loss of 
bacteriocinogenicity during serial dilution of subcultures or long-term storage 
has been demonstrated and reported for strains of L. helveticus (Upreti and 
Hindsdill, 1975), B. megaterium (Holland and Roberts, 1964), S. aureus 
(Barrow, 1963), and various streptococci (Tzannetis et al., 1974; Kuttner, 
1966). Often the loss of plasmids can be accelerated by exposing the producer 
strain to curing agents or by growing the strain at elevated temperatures. 
Bacteriocinogenic strains of S. aureus (Dajani and Taube, 1974; Warren et al., 
1974), L. acidophilus (Barefoot and Klaenhammer, 1983), L. helveticus 
(Daeschel and Klaenhammer, 1985), and Streptococcus lactis (Steele and 
McKay, 1986) have been cured of their plasmids by treatment with acriflavin, 
acridine orange, rifampin, novobiocin, and/or ethidium bromide. The use of 
elevated temperatures has been successful in curing pediococcal strains of their 
bacteriocinogenic factors (Gonzales and Kunka, 1987). 
Barefoot and Klaenhammer (1983) were unable to demonstrate the presence 
of plasmids in L. acidophilus N2. Therefore, these investigators concluded that 
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the bacteriocin determinant was located on the chromosome. Similarly, Joerger 
and Klaenhammer (1986) concluded that helveticin 481, produced by L. 
helveticus, must be encoded by the chromosome, since strains cured of 
plasmids still produced bacteriocin. 
Nisin is one of a number of peptide bacteriocins that are synthesized by 
post-translational processing of a precursor protein. Post-translational 
processing converts 13 of the 34 amino acid residues into unusual 
dehydroalanine and dehydrobutyrine residues (Liu and Hansen, 1990). Primer 
extension of messenger RNA was used to analyze nisin-encoding transcripts for 
upstream sequences (Steen et al., 1991). An oligonucleotide that was 
complementary to the nisin gene sequence was used as the primer for generating 
cDNA species. Subsequent DNA sequencing revealed a putative promoter 4 kb 
upstream from the nisin gene. The nisin gene was sequenced to reveal an 851-
amino acid coding region and an upstream putative mRNA processing site. 
These investigators suggested that the nisin gene is part of a polycistronic 
operon with a size greater than 8.5 kb. Subsequent DNA hybridization work 
using pulsed field electrophoresis located the nisin gene on a megabase-size 
DNA fragment located within the chromosome (Steen et ai, 1991). 
Molecular Cloning of Bacteriocin Genes 
Cloning of bacteriocin genes has recently been reported. Plasmid 
p9B4-6, a 60-kb plasmid from Lactobacillus lactis subsp. cremoris strain 9B4, 
encodes for two distinct bacteriocins and immunity proteins (van Belkum et al., 
1989). The plasmid was digested with restriction endonucleases and the DNA 
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fragments from this plasmid were cloned into an E. coli-Lactobacillus shuttle 
vector pWVOl. Clones of E.coli containing different recombinant plasmids 
produced different amounts of bacteriocin. A 1,8-kb DNA fragment from 
p9B4-6 encoded for a bacteriocin with low antagonistic activity, whereas a 1.3-
kb DNA fragment located within a 15-kb fragment encoded for high antagonistic 
activity. The two bacteriocins inhibited different spectra of organisms. Both of 
the DNA fragments have been sequenced and analyzed (van Belkum et ah, 
1991). The 1.8-kb DNA fragment contained three open reading frames (ORFs), 
which were organized into an operon. The first two ORFs were found to be 
involved in bacteriocin activity, whereas the third ORF was essential for 
immunity. A 4-kb subfragment of the 15-kb fragment strongly hybridized to the 
1.8-kb fragment (van Belkum et al., 1989). Mutagenesis of this subfragment 
showed that its first ORF was responsible for bacteriocin activity and its other 
ORF was responsible for immunity (Belkum et al., 1991). Partial nucleotide 
sequences of both fragments were obtained. The first 20 base pairs of the first 
ORFs as well as the upstream regions of both bacteriocin opérons were 
identical. 
Immunity to Bacteriocins 
A neccessary property to ensure the survival of producing organisms is the 
presence of specific immunity to the bacteriocin. A highly specific interaction 
between the bacteriocin and a protein that inhibits its activity is the basis for the 
immunity system. Bacteriocin immunity is a separate phenomenon from 
bacteriocin resistance. The latter is determined by the presence or absence of the 
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specific cell membrane receptor for a particular bacteriocin (Tagg et al., 1976). 
Resistant strains are characterized by inability to adsorb the bacteriocin from 
solution. In contrast, bacteriocin may be adsorbed onto resistant cells in high 
concentrations but for unknown reasons be ineffective in killing the cell (Tagg et 
al, 1976). 
Gonzales and Kunka (1987) found that both sensitive and resistant 
pediococci bound purified pediocin PA-1 at comparable levels, suggesting that 
the specificity of PA-1 may not be entirely dependent upon the presence of a 
specific receptor on sensitive cells. These results are similar to those reported 
by Barefoot and Klaenhammer (1983) for lactocin B. These investigators 
demonstrated adsorption of bacteriocin to cells of both sensitive and resistant 
Lactobacillus species. Nonlethal binding has been observed for other 
bacteriocins, such as staphylococcin produced by Staphylococcus aureus 
(Gagliano and Hindsdill, 1970) and lactocin LP27 produced by Lactobacillus 
helveticus (Upreti and Hindsdill, 1973, 1975). 
The structural gene(s) for immunity protein subunit(s) has been shown to 
reside on bacteriocin-determining plasmids in Escherichia coli, Pediococcus 
acidilactici, and lactobacilli (Belkum et ai, 1991; Koning et ai, 1976). The 
immunity gene(s) are expressed constitutively and maintained at certain 
concentrations in bacteriocin-producing cells. A general model for immunity to 
bacteriocins has been proposed; upon synthesis, the bacteriocins interact with 
their respective immunity proteins to form inactive complexes (Davies and 
Reeves, 1975). Thus, the producing cell is protected from the action of 
endogenous bacteriocin until it can be released from the cell. The mechanism 
whereby the immunity protein is released from the bacteriocin is unknown. It 
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has been suggested that the bacteriocin-immunity complex may interact with a 
cellular outer membrane receptor, but in vitro attempts to verify this mechanism 
have not been successful (Oudega, 1979). Nevertheless, it seems plausible that 
cellular immunity could arise by neutralization, in which incoming bacteriocin is 
inactivated by the binding of free intracellular immunity protein. 
Mode of Action of Bacteriocin 
Role of the receptor. The activity of a particular bacteriocin is dependent 
upon the presence of an appropiate receptor on susceptible organisms. 
Generally, most bacteriocins in gram-negative microorganisms act on different 
species within a given genus. In contrast, most bacteriocins of gram-positive 
bacteria exhibit activity against a wide range of gram-positive species, and 
several gram-negative microorganisms as well (Daeschel and Klaenhammer, 
1985; Gonzales and Kunka, 1987; Harris et a/.,1989; Vincent et al., 1959; 
Wolff and Duncan, 1974). 
Gram-negative bacteriocins have been studied most as models for 
bacteriocin activity. The study of receptor participation in bacteriocin absorption 
has been limited to the colicins. Putative receptors for many gram-positive 
bacteriocins have not been identified. 
Colicin receptors are involved in both nutrient and bacteriocin uptake. For 
example, the receptors for colicins El, E2, and E3 function also as vitamin B12 
receptors (Bassford et al., 1977; DiMasi et al., 1973). Colicin la and lb 
receptors are involved in iron uptake, serving as both siderophore-binding 
proteins as well as bacteriocin binding sites (Bowles and Konisky, 1981). 
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Colicin K receptors serve as specific diffusion pathways for nucleosides 
(Bassford et al., 1977; DiMasi et al., 1973). The dual function of these 
receptors implies that there is selective pressure for receptor maintenance on the 
surface of sensitive microorganisms. The events required for adsorption to 
receptors and the final interaction of the colicin at its target site are not known. 
Biochemical lesion. The mechanism of action of bacteriocins has been 
elucidated through studies of several E. coli colicins (Nomura, 1967). The 
action of a bacteriocin on sensitive cells has been suggested to occur in two 
stages. First, the bacteriocin absorbs to receptors on the cell membrane. 
Removal of the bacteriocin at this stage is reversible, with no permanent 
physiological damage produced and the sensitive cell left intact. In the second 
stage, irreversible physiological changes are effected that result in lysis of the 
cell. Nomura (1967) was able to demonstrate the irreversible stage by adding 
radioactive colicin to sensitive cells. Once adsorbed, the colicin was not 
displaced by "cold" coHcin, confirming the fact that colicin was bound 
irreversibly. 
Colicins A, El, la, lb, and K form ion-permeable channels in the bacterial 
cytoplasmic membrane. These bacteriocins inhibit both protein and nucleic acid 
synthesis, and uncouple electron transport (Boon, 1971; Daneu etal., 1969; 
Gilchrist and Konisky, 1975; Jakes, 1982; Levison et al., 1968; Nagel de 
Zwaig, 1969). Colicin-treated cells leak potassium (Feingold, 1970; Gilchrist 
and Konisky, 1975; Nagel de Zwaig, 1969) and are more permeable to 
magnesium and cobalt (Lusk and Nelson, 1972). The loss of intracellular 
potassium and magnesium was suggested by Kopecky et al. (1975) to be the 
primary cause of cell death. The ATPase activity was reduced in cells treated 
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with colicin El and K; subsequently this resulted in lower concentrations of 
intracellular ATP (Feingold, 1970; Plate et al., 1974; Sabet, 1976). In general, 
the inhibition of macromolecular synthesis by colicins A, El, la, lb and K is the 
result of several factors including (1) low concentrations of intracellular ATP, 
(2) inabihty to accumulate substrates by active transport, and (3) inability to 
maintain sufficient concentrations of cations and cofactors. 
The modes of action at the molecular level and immunity systems of colicins 
E2 and E3 have been thoroughly described in several reviews (Nomura, 1967; 
Tagg et aL, 1975). Colicins E3 and E2 are enzymes having RNase and DNase 
activity, respectively. Nomura (1963) demonstrated that colicin E3 inhibited the 
ability of E. coli cells to synthesize proteins. Ribosomes isolated from E3-
treated cells were shown to be incapable of supporting in vitro protein synthesis 
(Konisky and Nomura, 1967). Ribosomal damage was restricted to the 16S 
rRNA subunit, which apparently sustained a single nucleolytic cleavage near the 
3'- terminus of the molecule (Bowman et ai, 1971). This RNase activity was 
verified by observing the action of purified colicin E3 on ribosomes; again 
cleavage occurred at the same position on the 3' end of the 16S rRNA molecule 
(Boon, 1971; Ohno and Imahori, 1978). 
Treatment of E. coli with colicin E2 leads to specific inhibition of DNA 
synthesis and induces DNA degradation (Nomura, 1963). Highly purified 
colicin E2 exhibited DNase activity but not RNase activity when added to E, coli 
cells (Saxe, 1975). For the observed in vivo action to occur, both E2 and E3 
must first penetrate the cell surface and then interact directly with their target 
molecules. 
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Specific targets for a number of bacteriocins produced by gram-positive 
microorganisms have been identified. These targets have included energy 
production, DNA and/or RNA synthesis, and cell membrane transport and 
permeability. Upreti and Hindsdill (1975) reported that lactocin LP27 inhibited 
active potassium transport. Staphylococcin 462 was reported by Hale and 
Hindsdill (1975) to inhibit ATP production in the cell membrane. Clawson and 
Dajani (1970) described several morphological changes in streptococcal strains 
after exposure to staphylococcin C55. These included the condensation of 
DNA, loss of ribosomes, and loss of cell wall integrity. 
The mode of action of staphylococcin 1580 was found to be similar to that 
of channel-forming colicins. Staphylococcin-treated cells of S. aureus 
experienced rapid inhibition of macromolecular synthesis, depletion of ATP, 
and loss of intracellular rubidium ion (Gagliano and Hindsdill, 1970). 
Clostridium butyricum 7423 was reported to produce a hydrophobic bacteriocin 
(MW 32,000) active against Clostridium pasteurianum (Clarke and Morris, 
1976). Bacteriocin-treated cells were inhibited in DNA, RNA, and protein 
synthesis. Clarke and Morris (1976) suggested that the primary action of the 
bacteriocin was a stoichiometric inhibition of FiFQ-ATPase. The exact 
mechanism of its interaction with the cell membrane was unknown. 
Some gram-positive bacteriocins cause cell lysis or spheroplast formation. 
Monocins (Hamon and Peron, 1968), perfringocin 11105 (Clarke et al., 1975), 
and boticen E-25 (Anastasio et al., 1971) have been shown to cause cell lysis. 
Some bacteriocins, such as boticin P-PM16 (Lau et al., 1974), boticen E-55 
(Anastasio et ai, 1971), and clostricin BP6K-N (Sebald and Ionesco, 1974), 
have been shown to interfere with spore formation. Bacteriocin 28 of C. 
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perfringens acts on the cell walls of indicator organisms and converts them to 
spheroplasts (Mahony etaL, 1971). 
The lethal action of many bacteriocins may be attributed to direct enzymatic 
activity or to the activation of endogenous suicidal enzymes. For example, 
megacin C-C4, produced by B. megaterium C4, seems to activate endogenous 
DNase (Holland, 1963,1965). 
Adsorption of bacteriocin. If bacteriocin adsorbs to specific receptors on 
the cell wall of sensitive microorganisms, then it is reasonable to ask how many 
of these receptors must bind bacteriocin in order to kill a sensitive cell. The 
number of bacteriocin molecules required to kill a cell can be determined by 
studying the kinetics of adsorption measured as killing. The absorption of 
bacteriocin is generally demonstrated indirectly by a decrease in bacteriocin titer 
after mixing with an excess of sensitive cells. Adsorption studies are run by 
mixing various concentrations of bacteriocin with a known concentration of 
microorganisms (Shannon and Hedges, 1967). At 10-second intervals, samples 
are taken, diluted to prevent further adsorption of bacteriocin, and plated for 
viable counts. 
In one study conducted with colicin, Nomura (1967) noted that the number 
of viable cells decreased from the time the colicin was added at a rate dependent 
on the initial concentration of the bacteriocin. If a single molecule of bacteriocin 
can kiU a cell, then the rate of killing should be proportional to the rate at which 
bacteriocin adsorbs to cells. The rate should follow the kinetic equation: 
- dB/dt = kBC, 
where B = concentration of viable bacteria and C = concentration of bacteriocin. 
If the log of the relative population of surviving bacteria (Bt/Bo) is plotted as a 
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function of time, a straight line with a slope proportional to C should be 
obtained. This slope will be dependent on (1) the concentration of bacteriocin, 
(2) the number of receptors on the microorganism, and (3) the reaction constant 
for the reaction between the receptor and bacteriocin. 
In other studies in the presence of excess colicin, the slope of the kill curve 
changed as incubation continued (Shannon and Hedges, 1967). The authors 
postulated that heterogeneity in the number of receptors per cell caused this 
measured change. The initial slope was used to determine the average number 
of receptors per microorganism, and the final slope was used to describe the 
most resistant surviving bacteria {i.e. those with the lowest number of 
receptors). 
In contrast to "single-hit" killing, cumulative action of more than one 
molecule of bacteriocin on a single cell is defined as "multi-hit" killing (Shannon 
and Hedges, 1967). The kinetics of multi-hit killing are dependent on both the 
number of "hits" required to kill and the number of receptors per cell. In this 
situation, the plot of log (Bt/Bo) against time should have an initial shoulder that 
represents cumulative "hits" by the bacteriocin molecules. Shoulders have not 
been reported in kinetic studies of bacteriocin killing. Gagliano and Hindsdill 
(1970) have suggested that bacteriocins behave as particulate lethal agents, 
killing sensitive microorganisms with what is called "quantal" killing. This is 
the result of one bacteriocin molecule killing one sensitive cell in a single-hit 
process, in contrast to the "molar" or cooperative killing action of antibiotic 
molecules (Gagliano and Hindsdill, 1970). 
The adsorption of colicin to specific receptors has been well documented; 
however, very little is known about gram-positive receptors and the conditions 
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required for adsorption. Several physiological and physical conditions seem to 
be required for irreverible binding of bacteriocin. Sensitivity to streptococcin A-
FF22 (Tagg et al., 1973), staphylococcin 1585 (Jetten and Vogels, 1974), and 
clostocin 28 (Mahony and Butler, 1971; Mahony, 1974) depends upon the 
presence of actively multiplying cells; therefore, the physiological state of the 
indicator cells seems to have a strong influence on susceptibility to lethal action 
of bacteriocins. 
The temperature of incubation of indicator strains affects the rate of kiU by 
bacteriocins (Jetten and Vogels, 1974). Indicator cells grown at 37^0 were 
more sensitive to staphylococcin 1580 than were cells grown at 20OC. The 
lethal effects of the staphylococcin were also pH-dependent, with optimal killing 
at pH 7 to 8 (Jetten and Vogels, 1974). 
Functional and Structural Domains of Bacteriocins 
Little is known regarding the structure and function of bacteriocins produced 
by gram-positive organisms. Tlie only bacteriocins whose structure and 
function have been extensively studied are the colicins. Protease digestion has 
been used to study function of colicins E2, E3, and DF13 (Andreoli et al., 
1978; Cole et al., 1985; Gaastra et al., 1978). Nuclease activity of E2, E3 and 
DF13 comprised 25% of the total polypeptide and was located in the C-terminus 
(Mooi and DeGraaf, 1976; Ohno et al., 1977; Ohno and Imahori, 1978). The 
N-terminal regions of colicins E2, E3, and DF13, comprising approximately 
25% of the polypeptides, were postulated to be involved in translocation across 
the cell membrane (Cardelli and Konisky, 1974; Ohno and Imahori, 1978; 
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Yamamoto et al., 1979). The central portion of the polypeptide was found to 
interact with the outer membrane receptor (Ohno-Iwashita and Imahori, 1978). 
Digestion of subunits of colicins E2 and E3 with trypsin cleaved the 
polypeptides into an N-terminal fragment representing 70% of the protein and a 
C-terminal fragment. Analysis of the N-termini of colicins E2 and E3 showed a 
high degree of amino acid homology and antigenic specificity (Hershman and 
Helinski, 1967, Ohno-Iwashita and Imahori, 1979). These results support the 
findings of Maeda and Nomura (1966) who reported that both E2 and E3 
colicins bind to an identical outer membrane receptor. The tryptic C-terminal 
fragments of colicins E2 and E3 were found to be nonhomologous in their 
amino acid composition (Ohno-Iwashita and Imahori, 1979). These 
nonhomlogous domains were found to be the RNase and DNase regions of 
colicins E2 and E3, respectively. The C-terminus regions of E2 and E3 bound 
the immunity proteins, which subsequently neutralized the activity of the 
colicins. Binding of the immunity protein protected the colicin from protease 
attack; this may explain why colicins are not digested by proteases in the cell 
wall (Bowles and Konisky, 1981; Brey, 1981; Cavard and Lazdunski, 1979). 
The elongated shapes of colicins El ( MW 56,000), la (MW 79,000), lb 
(MW 80,0(X)), and K (MW 45,000) probably relate to their mechanism of action 
(Watson, 1980). These colicins contain a high concentration of polar amino 
acid, which may align as elongated structures in aqueous environments 
(Watson, 1980). It has been proposed that the N-terminal end of coHcins 
interact with the outer membrane proteins of the sensitive cells, bringing about 
conformational changes within the colicin molecule (Gaastra et al., 1977; Suit et 
al., 1985; Watson, 1980). Once bound, the C-terminal end is then brought into 
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contact with the cytoplasmic membrane; the C-terminal then targets various sites 
within the cell. Protease digestion of colicin El cleaved off the C-terminus, 
which was found to contain a large number of nonpolar amino acids (Dankert et 
al., 1981). For colicins like El, la, lb and K, the C-terminal segment, upon 
interacting with the cytoplasmic membrane, presumably undergoes further 
conformational changes that generate a transmembrane channel lined with 
hydrophilic amino acids (Martinez et ai, 1983; Kayalar and Luria, 1979). 
These functional channels are produced also in artificial phospholipid 
membranes, an observation which would exclude participation of bacterial 
polypeptides in channel generation (Cramer et ai, 1983). 
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SECTION I. PARTIAL PURIFICATION AND CHARACTERIZATION OF A 
BACTERIOCIN PRODUCED BY PROPIONIBACTERIUM 
THOENII 
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ABSTRACT 
A partially purified bacteriocin produced by Propionibacterium thoenii 
designated propionicin PLG-1 was found to be active against closely related 
species and exhibited a broad spectrum of activity against other microorganisms. 
Propionicin PLG-1 was found to be heat-labile, sensitive to several proteolytic 
enzymes, and stable at pH 3-9. Propionicin PLG-1 was isolated from solid 
medium, partially purified by ammonium sulfate precipitation, and purified 
further by gel filtration. Gel filtration experiments revealed that the bacteriocin 
PLG-1 was present as two different protein aggregates with apparent molecular 
weights greater than 150,000 and approximately 10,000. Resolution of these 
protein aggregates by sodium dodecyl sulfate -polyacrylamide gel 
electrophoresis revealed the presence of a protein common to both with apparent 
molecular weight 10,000. 
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INTRODUCTION 
Propionibacterium species were first described by Orla-Jensen in 1909 who 
divided them into two principal groups: the classical or dairy propionibacteria 
and the acnes or cutaneous propionibacteria (19). The classical propionibacteria 
are used in dairy fermentations and may contribute to natural fermentations of 
silage and olives (5,21). As dairy starter cultures, the propionibacteria are used 
to produce the characteristic eyes and flavor of Swiss-type cheeses (4,15). 
Bacteriocins, which are produced by a heterogeneous group of 
microorganisms, have a wide range of chemical properties, modes of action, 
and antibacterial spectra (24). Tagg et al. (24) defined bacteriocins as protein-
containing molecules that exert a bactericidal mode of action on closely related 
species. Although numerous bacteriocins from gram-positive organisms have 
been isolated, characterized, and purified (3, 8,10), few have been 
characterized and identified in the propionibacteria. Both classical and 
cutaneous propionibacteria have been shown to produce bacteriocins (11,20). 
Al-Zoreky (2) showed that Microgard (Wesman Foods, Inc., Beaverton, OR), a 
pasteurized grade A skim milk product fermented by Propionibacterium 
shermanii, has antagonistic effects against gram-negative bacteria and some 
yeasts and molds, but not against gram-positive bacteria. This product has been 
approved by the Food and Drug Administration and is currently being used as a 
preservative in cottage cheese (7). 
Propionibacterium thoenii strain PI27 from the Iowa State University 
culture collection was found to have inhibitory activity against other classical 
propionibacteria (11). The nature of the inhibitory substance(s) produced by 
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this strain was not defined. In the current study, the inhibitory substance 
produced by strain PI27 was isolated, partially purified, and found to be a 
protein with bactericidal activity against a wide spectrum of microorganisms. 
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MATERIALS AND METHODS 
Bacterial cultures. Strains of microorganisms used in this study 
(Tables 1,2) were obtained from the stock culture collection maintained by the 
Department of Food Science and Human Nutrition at Iowa State University. 
Identification of the various propionibacteria was verified by gram-stain, 
carbohydrate fermentation patterns (6), and HPLC analysis of culture 
supematants for the presence of propionic and acetic acids. 
The propionibacteria were propagated in screw-capped tubes of sodium 
lactate broth (NLB, 10 ml) at 320C. Propionibacteria and Clostridia were grown 
anaerobically by using the BBL anaerobic Gas-Pak system. All other 
microorganisms used in this study were grown in the media indicated in Tables 
1 and 2. Brain-heart infusion broth (BHl), Bacto APT broth (APT), Czapek-
Dox broth, Lactobacillii MRS broth (MRS) and thioglycollate were obtained 
from Difco Laboratories (Detroit, Ml) and were supplemented with 1.5% Bacto 
Agar as needed. Frozen stocks were maintained at -SO^C in the appropiate 
medium with 50% glycerol added. 
Bacteriocin assays. P. acidipropionici strain P5 was routinely used as 
the indicator strain in bacteriocin assays. The test strain, Propionibacterium 
thoenii PI27, and the indicator strain were grown for 18 h in NLB before use. 
Other organisms were grown in the appropriate medium to mid-logarithmic 
phase. Antimicrobial activity of the producer strain was measured by an agar 
spot assay (17). Activity of partially purified bacteriocin preparations was 
measured by a well diffusion method (17,25) or by the critical dilution method 
(17). Activity was defined as the reciprocal of the highest dilution causing 
complete inhibition of the indicator lawn and was expressed as arbitary units 
(AU) per ml. Approximately 10^ cells of indicator organisms were added to 
0.4% soft agar overlays. Controls for all assays included the examination of 
dilution buffers for inhibition of the indicator strains. Plates were incubated as 
appropriate for the indicator organisms. Diameters of the clear zones of 
inhibition were measured in mm. All assays were performed in duplicate, and 
results presented are the means of duplicate trials. 
Mitomycin C and ultraviolet light induction of bacteriocin. 
Strain P127 was inoculated into screw-capped test tubes of NLB and incubated 
at 320C for 18 h. Mitomycin C (Sigma Chemical Co., St. Louis, MO) was 
added at a final concentration of 1.0 |ig/ml and incubation was continued at 
320C. Samples (1 ml) were removed at 60,120, 240, and 360 min, centrifiiged 
to remove the cells, and the supematants (200 |il) were analyzed by the well 
diffusion method. 
A 10-ml sample of PI 27 culture grown for 18 h in NLB was placed in a 
sterile petri dish and exposed to short-wave ultraviolet light (256 nm) from a 15 
watt General Electric germicidal bulb at a distance of 20 cm. Times of exposure 
ranged from 0 to 30 sec. After exposure, the cell suspension was reincubated at 
320C for 12 h, centrifuged, and the supernatant (100 |il) was analyzed for 
bacteriocin activity by the well diffusion method. 
Preparation of partially purified bacteriocin. Eighteen-hour 
cultures of strain PI 27 were swabbed across the entire surface of petri plates 
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each containing 15 ml NLA made with 0,4% agar. The plates were incubated 
anaerobically for 5 days at 320C, stored at -20OC for 24 h, and thawed at room 
temperature for 3 h. The collapsed agar mixture was poured into sterile Whirl-
Pak bags (Nasco, Fort Atkinson, WI), massaged to break up the agar 
fragments, and allowed to equilibrate for 18 h at 40(1 The agar suspension was 
filtered through Whatman No. 1 filter paper (Fisher Scientific Co., Pittsburg, 
PA) and the filtrate was centrifuged at 12,000 x g for 20 min to remove agar 
fragments and bacterial cells. Ammonium sulfate was added slowly to the 
supernatant until the final concentration was 60%(w/v). The mixture was 
slowly stirred at 40C for 1 h and filtered through cheesecloth. Precipitated 
protein was removed by centrifugation at 25,000 x g for 30 min, resuspended 
in 0.05 M potassium phosphate buffer (pH 7.0) and dialyzed against 2 L of the 
same buffer for 18 h in Spectra/Por no. 4 dialysis tubing (Spectrum Medical 
Industries, Los Angeles, CA; molecular weight cutoff, 12,000 -14,000). The 
preparation was concentrated to 5 ml by dialysis against polyethylene glycol 
(PEG; Carbowax 20,000, Sigma) and filtered through a 0.45 |im Durapore filter 
(Millipore Product Division, Bedford, MA). This preparation was designated as 
partially purified bacteriocin. 
Sensitivity to enzymes and heat. A sample of partially purified 
bacteriocin was assessed for its sensitivity to various enzymes and heat 
treatments. Enzymes (all obtained from Sigma) and their respective buffers 
were pronase E (type XXV, 4.1 U/mg), 0.01 M sodium borate, 0.05 M HCl, 5 
mM CaCl2, ImM CoCl2 (pH 7.2); a-chymotrypsin (type II, 47 U/mg), 0.05 M 
Tris hydrochloride (pH 8.0), 0.01 M CaCl2; protease (type V, 1 U/mg), 0.05 M 
Tris hydrochloride (pH 8.0); catalase (2000 U/mg), 10 mM potassium 
phosphate (pH 7.0); phospholipase C (type 1,10 U/mg), 0.05 M Tris 
hydrochloride (pH 7.0), 0.01 M CaCl2; pepsin (3,200 lU/ml), 0.2 M citrate 
(pH 6.0); trypsin (type IX, 15,000 U/mg), 0.05 M Tris hydrochloride (pH 
8.0); lipase (type 1, 8.6 U/mg), 0.05 M Tris hydrochloride (pH 8.0), 0.01 M 
CaCl2; papain (EC 3.4.22.2,16 U/mg), 0.05 M acetate (pH 4.5), 0.2 M NaCl. 
The bacteriocin preparation (500 |il, 64 AU/ml) was incubated with 5(X) )J,1 
of each enzyme for 60 min at 37^0 except for samples containing trypsin, a-
chymotrypsin, and catalase, which were incubated at 250C. Prior to assaying 
for bacteriocin activity, preparations containing papain were adjusted to pH 6.0 
and those containing trypsin and chymotrypsin were treated with trypsin-
chymotrypsin inhibitor (Sigma) according to the manufacturer's instructions. 
Temperature stability was determined by heating a 1-ml sample of partially 
purified bacteriocin (protein concentration 500 |J,g/ml, 64 AU/ml) in glass test 
tubes (10 X 75 mm) at the times and temperatures listed in 
Table 3. After heat treatment, 500-|il samples were assayed for remaining 
activity by the well diffusion method. 
Tests for effects of organic acids. The concentrations of propionic 
and acetic acid produced by strain PI27 were measured by high performance 
liquid chromatography (HPLC). The strain was grown in NLB for 5 days, the 
culture was centrifuged, and the supernatant was filtered through a 0.22 |im 
Durapore filter. A 20-|il sample was injected into a Waters HPLC model 501 
(Waters Inc., Milford, MA) equipped with an Aminex HPX-87H column (Bio-
Rad Chemical Division, Richman, CA) that was run at 650C. The mobile phase 
was 0.012 N H2 SO4 at a flow rate of 0.8 ml/min. Organic acids were detected 
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by a refractive index detector, model R401 (Waters Inc.). Peaks were identified 
and quantified by retention times compared to standards. 
pH stability of bacteriocin activity. Partially purified bacteriocin 
samples (1 ml, 64 AU/ml) were individually dialyzed for 24 h against 2-L 
volumes of the following buffers: 0,05 M citrate buffer (pH 3,4, 5, 6), 0.05 M 
potassium phosphate buffer (pH 7), 0.05 M Tris-HCl (pH 8, 9). Three changes 
of each buffer were made during dialysis. After dialysis, the bacteriocin 
solutions (200 |iL) were assayed for activity by the well diffusion method. 
Adsorption studies. Adsorption of partially purified bacteriocin to 
bacterial cells was studied by modifying the method of Barefoot and 
Klaenhammer (3). Strains P5 and P127 were grown in NLB for 18 h, 
harvested by centrifugation, washed in 0.05 M potassium phosphate buffer (pH 
7.0), and resuspended at a final concentration of approximately 10^ cells/ml in 
500 |il of a preparation of partially purified bacteriocin (32 AU/ml). The 
suspensions were incubated for 0, 30, and 60 min at 320C, the absorption was 
measured at 600 nm, the cells were removed by centrifugation, and the 
supematants were filtered through a 0.45 |im Durapore filter. The bacteriocin 
activity of the filtrate was assayed by the well diffusion method. The cell pellet 
was washed with 0.05 M potassium phosphate buffer (pH 7.0), resuspended in 
1 ml of phosphate buffer, and viable counts were obtained on NLA plates by 
incubating the plates anaerobically at 32^0 for 5 days. 
Molecular weight determination. The molecular weight (MW) of the 
bacteriocin was determined by gel filtration. A 5-ml sample of partially purified 
bacteriocin in 0.05 M potassium phosphate buffer (pH 7.0) was applied to a 
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descending Sephadex G-200 column (2.5 x 42.8 cm; Phamiacia Fine 
Chemicals, Piscataway, NJ) at 40C, and eluted with 0.05 M potassium 
phosphate buffer (pH 7.0) at a flow rate of 0.40 ml/min. Protein in the eluent 
fractions was measured by determining the absorbance at 280 nm. Fractions 
with protein were pooled, concentrated tenfold by dialysis against polyethylene 
glycol (PEG), exhaustively dialyzed in SpectraPor no. 4 tubing against 0.05 M 
potassium phosphate buffer (pH 7.0) at 40C, filter-sterilized through a 0.45 mm 
Durapore membrane, and assayed for bacteriocin activity by the well diffusion 
method. Molecular weights were determined by comparison of elution volumes 
with those of known standards (14). Protein standards (Sigma) used were 
apoferritin, 6,500; cytochrome c, 12,400; carbonic anhydrase, 29,000; alcohol 
dehydrogenase, 150,000. 
Protein determinations. Protein in 50-p,l samples of partially purified 
bacteriocin was determined by the modified method of Lowry et al. (16) 
according to the specifications of the manufacturer (Sigma). Bovine serum 
albumin was used to construct a standard curve. 
Sodium dodecyl-sulfate-polyacrylamide gel electrophoresis. 
Polyacrylamide gel electrophoresis (PAGE) in the presence of 0.1% sodium 
dodecyl-sulfate (SDS) was performed on a vertical slab gel (1 mm) as described 
by Laemmli (14). Polyacrylamide and N,N'-methylenebisacrylamide (Sigma) 
concentrations in the stacking gel (10 ml) were 5% and 0.15%, respectively, 
and 20% and 0.5% in the separating gel (30 ml). Electrophoresis was 
conducted at a constant current of 30 m A for 4 h at 40C. The gel was stained 
with Coomassie brilliant blue-R (Sigma) and enhanced with silver stain (Sigma) 
4 8  
as described by Merril et al. (18). Protein standards and their molecular weights 
were ovalbumin, 43,000; carbonic anhydrase, 29,000; P-lactoglobulin, 18,400; 
lysozyme, 14,300; bovine trypsin inhibitor 6,200; a and P insulin, 3,000 
(Bethesda Research Laboratories, Gaithersburg, MD). 
RESULTS 
Conditions for production of inhibitory activity. Inhibitory 
activity of strain PI27 against strain P5 was observed only when cultures were 
grown on solidified agar. Activity was never seen in cell-free supematants of 
cultures grown in NLB, even after fivefold concentration by dialysis against 
PEG. Attempts to isolate propionicin PLG-1 from NLA yielded low 
concentrations of the bacteriocin that seemed to be associated with protein 
components of the medium (data not shown). Treatment of PI27 broth cultures 
with mitomycin C or ultraviolet light did not induce production of inhibitory 
activity. Inhibitory activity could be measured only after strain P127 was grown 
for at least 24 h on NLA; maximum inhibitory activity was seen after 
approximately 140 h. 
Inhibitory activity could be separated from cells of producer stain P127 by 
growing the strain in NLA that contained 0.4% agar, freezing the agar to 
collapse the gel structure, and removing cells and agar debris by centrifugation. 
This method was used to produce a crude preparation of bacteriocin, which was 
further purified by ammonium sulfate precipitation and dialysis against 0.05 M 
potassium phosphate buffer (pH 7.0). The resulting partially purified 
bacteriocin was then used in further tests. 
Inhibitory activity against other microorganisms. Partially 
purified bacteriocin was tested in well diffusion assays to evaluate its inhibitory 
activity against various microorganisms. Thirty-one strains of classical 
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propionibacteria from the culture collection were tested. All strains of P. 
freudenreichii svibs^.freudenreichii and P.freudenreichii subsp. shermanii 
were insensitive to this substance, but all strains of P. thoenii, P. 
acidipropionici, and P.jensenii were sensitive. Of the 15 tested strains of P. 
freudenreichii, none produced antimicrobial substances against other selected 
indicator strains of propionibacteria (data not shown). Producer strain P127 
was not inhibited by its own inhibitory factor. 
Table 1 presents results of well diffusion assays conducted with other 
bacteria. Lactic acid bacteria were inhibited, but tested strains of 
Staphylococcus aureus. Streptococcus faecalis (group D), 6 species of Bacillus 
and 2 species of Clostridium were not inhibited. Of the gram-negative 
organisms tested, strains of Pseudomonas were most sensitive. Representative 
strains of Aeromonas hydrophila. Yersinia enterocolitica, and 2 species of 
Salmonella were not inhibited. 
Inhibitory activity was also observed against some molds and yeasts (Table 
2). Hazy zones of inhibition observed with strains of Saccharomyces suggest 
that partial inhibition, or perhaps fungistatic rather than fungicidal activity, 
occurred. Of three species of Aspergillus tested, only A. wentii was inhibited. 
One strain each of Fusarium roseum and Pénicillium chrysogenum were not 
inhibited. 
Effects of enzymes and heat on the inhibitory substance. 
Samples of partially purified inhibitory subtance were found to be sensitive to 
protease, pronase E, pepsin, trypsin, and a-chymotrypsin, but were not 
affected by phospholipase C, lipase, or catalase (Table 3). Inactivation of 
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bacteriocin, in its native structural conformation, by pronase E was incomplete 
and may be attributed to the proteolytic requirement of pronase E for a free N-
terminal amino acid in its substrate (23). Inhibitory activity was unaffected by 
heating at moderate temperatures, but was rapidly lost by heating at temperatures 
greater than 850C (Table 3). Buffers and enzyme preparations alone had no 
effect on the indicator lawns. These data suggest that the inhibitory substance is 
a protein which is active against other strains of bacteria. We propose that it be 
designated a bacteriocin and given the name propionicin PLG-1. 
Other potential inhibitory substances. Propionibacteria can produce 
other inhibitory substances such as organic acids (propionate and acetate), 
diacetyl (2,3-butanedione), and hydrogen peroxide (7). Therefore, it was 
important to eliminate these compounds as the source of inhibitory activity 
produced by strain PI27. These inhibitory substances are of low molecular 
weight. In tlie preparation of partially purified bacteriocin, samples were 
exhaustively dialyzed against buffer in dialysis tubing with a molecular weight 
cutoff of 12,000 to 14,000. The inhibitory activity was retained in the dialysis 
bag, which suggests that it is not caused by low- molecular weight molecules. 
Strain PI27 was grown to stationary phase (144 h) in NLB, and the culture 
supernatant was analyzed for propionic and acetic acids by HPLC. Only 0.4% 
propionate and 0.2% acetate were present. In contrast, indicator strain P5 
tolerated up to 1.5% propionic acid when grown on gradient plates containing 0 
to 2.0% propionic acid. Partially purified bacteriocin preparations contained 
negligible amounts of propionic acid and no acetic acid. 
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The fact that catalase had no effect on inhibitory activity indicates that 
hydrogen peroxide is not the inhibitory factor (Table 3). These collective data 
indicate that the observed inhibitory activity is not due to low molecular weight 
substances such as organic acids or hydrogen peroxide nor to intolerance of the 
indicator strain P5 to propionic acid. 
pH stability of propionicin PLG-1. Partially purified bacteriocin 
was equilibrated in buffers with various pH values and assayed by the well 
diffusion method. Activity was greatest at pH 7.0, and was detected throughout 
the range of pH 3.0 to pH 9.0. At pH 7.0, the diameter of the zone of inhibition 
against indicator strain P5 was 22 mm while at acidic pH (3-4) there was partial 
lost of activity (diameter of the zone of inhibition was 11 mm). At pH 5-6 and 
8-9, the zones of inhibition were 14 mm and 18 mm, respectively. 
Effect of propionicin PLG-1 on sensitive and nonsensitive 
cells. Aliquots (500 |il) of partially purified bacteriocin were mixed with 500 
111 of cell suspensions of strains PI27 and P5. After incubation for 30 min, the 
cells were pelleted by centrifugation and enumerated for viable counts. Residual 
inhibitory activity of the supernatant was measured by the well diffusion 
method. Results are presented in Table 4. 
Viable counts of indicator strain P5 were reduced by 99.6% after exposure 
to propionicin PLG-1, but viable counts of strain PI27 were unchanged. 
Incubation longer than 30 min did not significantly change the number of viable 
microorganisms detected. Residual inhibitory activity was not detected in the 
supernatant of preparations mixed with strain P5 cells, but was unchanged in 
preparations mixed with P127 cells. These results suggest that propionicin 
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PLG-1 did not adsorb to the producer strain PI27, but did adsorb to indicator 
strain P5. The effect on sensitive cells was bactericidal, but no obvious cell 
lysis was seen. 
Molecular weight determination. Partially purified bacteriocin was 
applied to a descending Sephadex G-200 column. Protein was eluted in two 
peaks, and pooled fractions from these two peaks had antimicrobial activity. 
Molecular weights of active fractions were determined to be greater than 
150,000 and approximately 10,000, respectively, based on comparisons of 
mean elution volumes to those of protein standards (data not shown). 
The bacteriocin appeared to be associated with contaminating proteins from 
the medium. Applying the bacteriocin to a descending Sephadex G-50 column 
prior to application to a Sephadex G-200 column allowed some, but not 
complete, separation from these contaminants (data not shown). 
SDS-PAGE. When active fractions (60 |ig protein) from the second 
peak eluted from a Sephadex G-200 column were electrophoresed in a 
denaturing 20% polyacrylamide gel, a single diffused protein band was resolved 
with a molecular weight of approximately 10,000 (Fig. 1). Similarly, a fraction 
from the first peak resolved a protein band with molecular weight approximately 
10,000, but this fraction also contained approximately 12 contaminating 
proteins. 
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DISCUSSION 
The inhibitory substance produced by strain PI27 seems to be a large, 
relatively heat-labile protein that we have designated as propionicin PLG-1. 
Inhibitory activity produced by strain P127 was not detected in cell-free 
supematants of broth cultures, but was isolated from semi-solid medium. 
Similarly, Barefoot and Klaenhammer (3) were unable to isolate the bacteriocin 
lactacin B from broth cultures of Lactobacillus acidophilus, and could isolate 
only small quantities from agar plate cultures. 
One characteristic of classical bacteriocins is a narrow spectrum of activity 
(1, 24). More recent reports (8, 24) have shown that some bacteriocins 
produced by gram-positive bacteria have a broad spectrum of activity. The 
bacteriocin produced by strain PI 27 is active against some, but not all, of the 
classical Propionibacterium species, some other gram-positive organisms 
(especially lactic acid bacteria), some gram-negative organisms, and some yeasts 
and molds. Propionicin PLG-1 is different from Microgard, which contains an 
inhibitory substance of low molecular weight produced by a strain of P. 
freudenreichii subsp. shermanii. Microgard inhibits many gram-negative 
organisms, some molds and yeasts, but no gram-positive organisms. More 
extensive testing of the spectrum of activity will be performed with purified 
propionicin PLG-1. 
Propionicin PLG-1 was active over a wide pH range (pH 3 - 9), with 
greatest activity at pH 7. Similarly, Gonzalez and Kunka (9) found that 
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pediocin PA-1, a bacteriocin produced by Pediococcus acidilactici, was active 
over a wide pH range (4 - 7), with some loss of activity at pH 2, 3, 9, and 10. 
This stability to a wide range of pH values may be useful if propionicin PLG-1 
were used as an antimicrobial agent in fermented foods or other products. 
Tagg et al. (24) described bacteriocin action as a single-hit mechanism, in 
which the bacteriocin adsorbs to, penetrates, and kills sensitive cells in an 
irreversible process. Propionicin PLG-1 was found to adsorb to sensitive cells 
of strain P5 and to be bactericidal. Tagg et al. (24) suggested that bacteriocin 
resistance results from a lack of bacteriocin-specific receptors in the cell 
membrane, whereas bacteriocin immunity results from production of a 
substance, perhaps a protein, that binds to the bacteriocin and prevents lethal 
action on the producer cells. Propionicin PLG-1 did not adsorb to its producer 
strain and did not inliibit other closely related strains, but the mechanism of 
resistance is yet to be determined. Propionicin PLG-1 seems to be different 
from some bacteriocins isolated from other gram-positive organisms, which 
bind nonspecifically to both sensitive and nonsensitive cells (3,10). 
Cmde preparations of bacteriocin applied to a Sephadex-G200 column 
were eluted in two peaks that contained bacteriocin activity. Proteins in these 
peaks were estimated to have molecular weights of approximately 10,000, and 
greater than 150,000. After resolution by SDS-PAGE, a common diffused 
protein band of approximate MW 10,000 was found in active fractions. This 
protein may be the actual propionicin molecule. Its identity and activity await 
further determination. Results in the current study parallel those reported for 
lactacin B (MW 100,000) isolation (3). Both propionicin PLG-1 and lactacin B 
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were first isolated as large protein aggregates, and both bacteriocins were 
dissociated from other protein components by SDS-PAGE. The apparent 
association of this bacteriocin with other proteins, some of which probably 
originated in the culture medium, may require the development of a defined 
medium to optimize bacteriocin production and purification. Further purification 
and characterization of this bacteriocin are currently in progress. 
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Figure. 1. SDS-PAGE of fractions from protein peaks eluted from a 
Sephadex-G200 column to which partially purified bacteriocin preparation 
had been applied. Lane assignments: Lane 1, fraction from first peak 
(estimated MW 150,000); Lane 2, molecular weight standards (top to 
bottom): ovalbumin (MW 43,000), carbonic anhydrase (MW 29,000), P-
lactoglobulin (MW 18,4(X)), lysozyme (MW 14,300), bovine trypsin inhibitor 
(MW 6,2(X)), a and (3 insulin (MW 3,000); Lanes 3 and 5, fractions from 
second peak (estimated MW 10,000); Lane 4, empty 
1 2 3 4 5 
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TABLE L Bacterial strains inhibited by partially purified bacteriocin from strain 
PI27 using the well diffusion assay 
Gram-positive microorganisms 
Lactobacillus bulgaricus AR2 MRS, ST^C +2 
Lactobacillus bulgaricus IT6 MRS, SV^C +1 
Lactobacillus casei MRS, BV^C +2 
Pediococcus cerevisiae MRS, 32^0 +2 
Lactococcus lactis subsp. cremoris APT, 37^0 +2 
Lactococcus lactis ^v^sç.diacetylactis APT, 370C +2 
Lactococcus lactis subsp, lactis APT, 37^0 +3 
Gram-negative microorganisms 
Campylobacter jejuni Thioglycollate, 370C +2 
Escherichia coli mm TSB, 370C +1^ 
Escherichia coli V517 TSB, 370C +1^ 
Pseudomonas fluorescens BHl, 37^0 +4 
Pseudomonas aeruginosa BHl, 37^0 +4 
Vibrio parahaemolyticus BHl, 320C +3 
^ Diameter of the zone of inhibition: - no inhibition; +1, < 10 mm; +2,11-
14 mm; +3,15-17 mm; +4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
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TABLE 2. Yeast and mold strains inhibited by partially purified bacteriocin from 
strain P127 using the well diffusion assay 
Organism Growth conditions Zone of inhibition^ 
Aspergillus wentii ATCC 1778 Czapek Dox, 320C +2 
Apiotrichum curvatum Czapek Dox, 320C +1 
Candida utilis Czapek Dox, 320C +3 
Candida lipolytica Czapek Dox, 320C +lb 
Fusarium tricinctum Czapek Dox, 320C +1 
Phialophom gregata Czapek Dox, 320C +3 
Saccharomyces cerevesiae ATCC 24702 TSB,320C +lb 
Saccharomyces cerevesiae TSB,320C +lb 
Saccharomycopsis fibuligera Czapek Dox, 320C +3 
Scopulariopsis sp. Czapek Dox, 320C +3 
Trichoderma reesi Czapek Dox, 320C +3 
^ Diameter of the zone of inhibition ; - no inhibition; +1, < 10 mm; +2,11-
14 mm;+3,15-17 mm;+4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
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TABLE 3. Sensitivity of propionicin PLG-1 to various enzymatic and heat 
treatments 
Treatment Diameter of zone of inhibition ^ (mm) 
control (phosphate buffer) 14 
a-chymotrypsin 0 
protease 0 
papain 0 
pepsin 0 
trypsin 0 
pronase 9 
catalase 14 
lipase 14 
lysozyme 14 
phospholipase C 14 
control (no heat) 17 
750c for 60 min 17 
SO^C for 30 min 16 
850c for 15 min 10 
850C for 30 min 0 
90OC for 3 min 0 
lOO^C for 1 min 0 
^ All diameters are the means of duplicate tests. Range of duplicate 
diameters were +/- .02 mm. 
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TABLE 4. Culture viability and bacteriocin activity after incubating bacteriocin 
preparations with indicator or producer cells at 320C for 30 min 
Test mixture Diameter ^ Viable counts ^ % reduction ^ 
of zone of (cfu/ml) in viable counts 
inhibition (mm) 
Bacteriocin + buffer^ 14 
Cells + buffer 
Strain P127 - 3.3 x 108 0 
Strain P5 - 1.3 x 108 0 
Bacteriocin + cells 
Strain P127 14 3.2 xlO^ 3.0 
Strain P5 0 5.2 x 10^ 99.6 
^ Initial cell concentrations were 3.3 x 10^ CFU/ml for strain P127, and 1.3 
X 108 CFU/ml for P5. 500 |il of cell suspensions and/or 500 |il of partially 
purified bacteriocin (32 AU/ml) were used in each test. After incubation for 30 
min at 320C, residual bacteriocin activity was assayed by the well diffusion 
method. Zones were measured as diameters from the edge of the clearing zone, 
b % reduction was calculated as: 
cfu prior to incubation-cfu after incubation X 100 
cfu prior to incubation 
c Potassium phosphate buffer (0.05M; pH 7.0). 
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ABSTRACT 
Production of propionicin PLG-1 by Propionibacterium thoenii strain 
PI27 was pH-dependent, with maximum activity detected in supematants of 
cultures grown at pH 7.0. Propionicin PLG-1 was purified by ion-exchange 
and isoelectric focusing. Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis of propionicin PLG-1 purified through isoelectric focusing 
resolved a protein band with molecular weight 10,000. Propionicin PLG-1 
was bactericidal to sensitive cells, demonstrating single-hit kinetics. The 
producing strain was shown to harbor a single plasmid (pLGl) with 
approximate molecular weight 250 kb. Preliminary data indicate that both 
propionicin PLG-1 and immunity to the bacteriocin are encoded on the 
chromosome. Exposure of strain PI27 to acriflavin or to N-methyl-N'-nitro-
N-nitrosoguanidine yielded isolates that no longer produced bacteriocin activity 
and isolates that were cured of the plasmid. However, the loss of one trait was 
not correlated with the loss of the other. Isolates cured of the plasmid were 
phenotypically identical to plasmid-bearing cells in fermentation patterns, 
pigment production, and growth characteristics. 
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INTRODUCTION 
Bacteriocins, which are produced by a heterogeneous group of 
microorganisms, have a wide range of chemical properties, modes of action, 
and antibacterial spectra. Numerous bacteriocins have been isolated from 
different genera of bacteria (5,20). 
Propionibacterium species were first described in 1909 by Orla-Jensen, 
who divided them into two principal groups: the classical or dairy 
propionibacteria and the acnes or cutaneous propionibacteria (15). The 
classical propionibacteria are used in dairy fermentations and may contribute to 
natural fermentations of silage and olives (3,17). As dairy starter cultures, the 
propionibacteria are used to produce tlie characteristic eyes and flavor of 
Swiss-type cheeses (2, 10, 15). 
Although numerous bacteriocins from gram-positive organisms have been 
isolated, characterized, and purified, few have been identified in the 
propionibacteria (5, 8,19). Two bacteriocins have been reported in the acnes 
group (6,16) and three in the classical propionibacteria (12,21). We reported 
previously that a bacteriocin produced by P. thoenii strain PI27 was active 
against closely related species and exhibited a broad spectrum of activity 
against other microorganisms (12). Tliis bacteriocin, designated propionicin 
PLG-1, after partial purification was found to be heat-labile, sensitive to 
several proteolytic enzymes, and stable at pH 3-9. In this paper, we describe 
the production, isolation, and purification of propionicin PLG-1. 
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MATERIALS AND METHODS 
Cultures and media. Bacteriocin-producing strain P. thoenii 
(P127) and sensitive indicator strain P.acidipropionici (P5) were propagated as 
described previously (12). Media were prepared as previously described (12). 
Agrobacterium tumefaciens A281 was propagated in Nutrient Broth (Difco, 
Detroit, MI) with vigorous agitation at 25 OC. 
Production studies at controlled pH. A 1% (v/v) inoculum of an 
18-h broth culture of P. thoenii (P127) was used to inoculate a 1.5-L working 
volume Biostat M fermenter (B. Braun Biotech, Allentown, PA). Cultures 
were grown at 320C for 14 days and agitated at 150 rpm without aeration. The 
initial pH was adjusted to the specified pH with 3.0 M HCl, and during 
fermentation was controlled within the pH range of +/- 0.05 by the addition of 
3.0 M NaOH. At 12-h intervals, 25-ml samples were removed from the 
fermenter and evaluated for cell viability, turbidity (A600) and acid production. 
Periodically, 300-ml samples were removed and the bacteriocin was partially 
purified by ammonium sulfate precipitation as described below. 
Bacteriocin assays. Antimicrobial activity of the producer strain 
was measured by an agar spot assay (13). Activity of partially purified 
bacteriocin preparations was measured by a well diffusion method (13,20) or 
by the critical dilution method (13). Activity was defined as the reciprocal of 
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the highest dilution causing complete inhibition of the indicator lawn and was 
expressed as arbitrary units (AU) per ml. Approximately 10^ cells of indicator 
organisms were added to soft agar overlays. Plates were incubated 
anaerobicaUy for 2 days at 32^C. Diameters of the clear zones of inhibition 
were measured in mm. All assays were performed in duplicate, and results 
presented are the means of duplicate trials. 
Bactericidal action and adsorption studies. Cells from 18-h 
sodium lactate broth (NLB) cultures of strains PI27 and P5 were harvested by 
centrifugation (9,000 x g), washed in 0.05 M phosphate buffer and added at a 
final concentration of 3.8 x 10^ CFU/ml and 1.2 x 10^ CFU/ml, respectively, 
to a purified bacteriocin preparation (500 |il; 32 AU/ml). After 60 min of 
incubation, cultures were serially diluted in 0.2% peptone and survivors were 
counted on sodium lactate agar (NLA). Residual bacteriocin activity was 
assayed by the well diffusion method (13). 
Purification of propionicin PLG-1. 
(i). Initial steps. A 14-day culture of P. thoenii from the fermenter 
(1,000 ml) was centrifuged at 12,000 x g for 30 min at 4^0. Ammonium 
sulfate was added to the supernatant at 40% saturation at 40C, the suspension 
was slowly stirred for 30 min, and precipitated proteins were collected by 
centrifugation at 29,000 x g for 30 min at 40C. The supernatant was decanted 
and ammonium sulfate was added to it until 60% saturation was reached. 
Precipitated proteins were pelleted by centrifugation (29,000 x g), resuspended 
in 5 ml of 20 mM bis(2-hydroxyethyl)-iminotris-(hydroxymethyl) methane 
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(Bis-Tris; pH 7.0; Sigma Chemical Co., St Louis, MO), and dialyzed against 2 
L of the same buffer for 18 h in Spectra-Por no. 3 dialysis tubing (Spectrum 
Medical Industries, Los Angeles, CA; MW cutoff, 3,500). This preparation 
was designated as partially purified bacteriocin. 
(ii). Ion exchange chromatography. Partially purified bacteriocin (5 ml, 
100 AU/ml) was applied to both a descending DEAE-sepharose column 
(Sigma; 2.5 x 37 cm) equilibrated with 20 mM Bis-Tris (pH 7.0) at 40C, and 
a descending carboxymethyl-sepharose column (Sigma; 2.5 x 35 cm) 
equilibrated with 20 mM 2-(N-morpholino)-ethanesulfonic acid at 4^C (MES; 
pH 6.5; Sigma). Proteins were eluted from the columns with a linear salt 
gradient (0-1.0 M NaCl, 500 ml) in their respective buffers. Fractions (4 ml) 
were collected and their refractive indices were determined. Fractions 
containing protein were concentrated 5-fold by dialysis against Bio-gel 
concentrator (Bio-Rad Laboratories, Richmond, CA) and assayed for 
bacteriocin activity by the well diffusion method. 
(iii). Rotofor isoelectric focusing. A Rotofor isoelectric focusing chamber 
(Bio-Rad) was assembled as described by the manufacturer. Propionicin PLG-
1 was eluted from a carboxylmethyl sepharose column with MES (pH 6.5) 
containing 1 M NaCl. Fractions were assayed for propionicin PLG-1 activity 
by the well diffusion method and tlie fraction that contained activity was 
dialyzed overnight against a 5% glycerol solution that also contained 1 mM 
phenylmethyl sulfonyl fluoride (PMSF; Sigma), ImM EDTA, and 100 mM 
KCl. The Rotofor cell was prefocused with 40 ml of 5% glycerol in distilled 
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water containing 2% (v/v) Bio-lyte ampholytes (pH 3-10; Bio-Rad), 1 mM 
EDTA, and 100 mM KCl using 12 W constant power at 4^0 for 1 h to 
establish the pH gradient. The initial prefocus conditions were 300 V and 32 
mA, and at pH equilibrium, the values were 989 V and 22 mA. 
After prefocusing, the dialyzed bacteriocin sample was injected near the 
middle of the focusing chamber and the sample was focused for another 3 h at 
which time the final voltage was 848 V. Twenty fractions (1.5 ml) were 
harvested as described by the manufacturer and their pH values measured. 
Ampholytes were removed by dialyzing (Spectra-Por no. 3) against 100 
volumes of 1 M NaCl containing ImM EDTA and ImM PMSF. Individual 
fractions were assayed for bacteriocin activity by the critical dilution method 
(13) and the fraction containing activity was analyzed on an 18% tube SDS-
PAGE as described below. Buffer alone was assayed for potential inhibitory 
activity against the indicator strain. 
Mutant selection and plasmid analysis. Producer strain P. thoenii 
P127 was grown for 18 h at 320C in NLB containing various concentrations 
of acriflavin (5-50 jig/ml; Sigma) and N-methyl-N'-nitro-N-nitrosoguanidine 
(NG; 100-500 p-g/ml; Sigma) as described earlier (7,18). The percentage kill 
that resulted from exposure to mutagens was calculated as [(initial cell count -
number of survivors) / initial cell count] x 100. After mutagenesis, cultures 
were serially diluted and plated onto NLA. After incubation for 1 week at 
320C, 500 isolated colonies were transferred with sterile toothpicks onto 
duplicate master plates of NLA (7 colonies per plate), and reincubated for 7 
days. One plate was overlaid with soft NLA (5 ml, 0.7% agar) containing 100 
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|il of indicator strain P5 (10^ CFU/ml). After development of the overlaid 
lawn, individual PI 27 colonies were evaluated for bacteriocin production and 
selected colonies were transferred from the second master plate into 10 ml of 
NLB and grown for 24 h at 320C. These cultures were then inoculated at 1% 
into 100 ml of NLB and incubated at 32^C for 24 h to provide cultures to be 
screened for the presence of plasmid DNA. 
Plasmid DNA was isolated from mutants by using the procedure 
described by Rehberger (18) with the following modifications. After the 
addition of 5M NaCl, the cell debris was pelleted by centrifugation at 12,000 x 
g for 15 min. An aliquot of 13% polyethylene glycol (PEG, 8000 MW; 
Sigma) in 50 mM Tris-HCl, 10 mM Na2EDTA, pH 8.0 equal to one-half the 
volume of the supernatant was added and gently mixed by inversion. The tube 
was placed on ice for 18 h and precipitated plasmid DNA was pelleted by 
centrifugation at 12,(K)0 x g for 30 min. The DNA pellet was resuspended in 
250 III of 10 mM Tris-HCl, ImM Na2EDTA (pH 8.0), extracted with 250 |il 
phenol: chloroform: isoamyl alcohol (25:24:1) and centrifuged at 12,000 x g 
for 5 min. The upper phase was transferred to a fresh microcentrifuge tube, 
extracted with 250 |il chloroform: isoamyl alcohol (24:1), and the upper phase 
was transferred to a fresh tube. Residual amounts of phenol were removed by 
extracting twice with 250 ji.1 H20-saturated diethyl ether. The lower DNA 
phase was retained and residual ether was evaporated in a hood. 
Plasmid preparations were analyzed by electrophoresis in 0.6 % agarose 
gels. Mobility reference plasmids were isolated from Agrobacterium 
tumefaciens A281 by the method of Casses et al. (4). 
SDS-PAGE. SDS-PAGE in the presence of 0.1% SDS was performed 
as described by Laemmli (9). Polyacrylamide and N,N'-
methylenebisacrylamide (Sigma) concentrations in the stacking gel (1 ml) were 
5% and 0.15%, respectively, and 18% and 0.5% in the separating gel (10 ml). 
The gels were stained with Coomassie brilliant blue-R (Sigma) as described by 
Merril et al. (14). Protein standards and their molecular weights were 
ovalbumin, 43,000; carbonic anhydrase, 29,000; P-lactoglobulin, 18,400; 
lysozyme, 14,300; bovine trypsin inhibitor 6,200; a and (3 insulin, 3,000 (all 
from Bethesda Research Laboratories, Gaithersburg, MD). 
Protein determinations. Protein was determined by the modified 
method of Lowry et al. (11) according to the specifications of the manufacturer 
(Sigma). Bovine serum albumin was used to construct a standard curve. 
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RESULTS 
Effect of pH on propionicin production. Propionicin PLG-1 was 
initially isolated from semi-solid medium because attempts to isolate it from 
cell-free supematants of broth cultures were unsatisfactory (12). Since then 
we have been able to detect propionicin PLG-1 in the culture supernatant by 
allowing cultures to grow into late stationary phase. Propionicin PLG-1 was 
produced in very low concentration in the culture supernatant (0.83 AU/ml); 
therefore, large volumes of culture supernatant (1000 ml) were fractionated 
using ammonium sulfate and dialyzed prior to assaying for bacteriocin activity. 
After optimizing the conditions required for propionicin PLG-1 isolation, the 
optimal production of propionicin PLG-1 was evaluated during anaerobic 
growth of P. thoenii strain PI27 in NLB at controlled pH (Fig. 1). At pH 7.0, 
maximum production of propionicin (50 AU/ml) was observed at 180 h. 
Bacteriocin production was much less in cultures grown at pH 6.0, 6.5, and 
7.5 although culture growth was comparable to growth at pH 7.0. Growth at 
pH 8.0 was poor and maximum bacteriocin activity was only 5 AU/ml at 180 h 
(data not shown). 
Purification of propionicin. Propionicin PLG-1, which was found 
in the supernatant during late-exponential phase of growth, was concentrated 
approximately 600-fold from the culture medium by ammonium sulfate 
precipitation (Table 1). The specific activity increased from 0.64 AU/mg in the 
culture supernatant to 388 AU/mg after ammonium sulfate fractionation. When 
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partially purified propionicin was applied to a descending DEAE-sepharose 
column previously equilibrated with Bis-Tris (pH 6.5), all bacteriocin activity 
was recovered in the void volume (data not shown). Partially purified 
bacteriocin was applied to a carboxymethyl sepharose column and eluted with a 
salt gradient, proteins were eluted in four peaks (Fig. 2). The first two peaks 
were eluted between 0 - 0.2 M NaCl and the third peak between 0.4 -0.6 M 
NaCl. A single fraction eluted within the third peak contained bacteriocin 
activity (32 AU/ml). After passage through the carboxymethyl sepharose 
column, 12% of propionicin PLG-1 activity was recovered, and the specific 
activity was increased by 1200-fold (Table 1). 
The active fraction was then applied to the Rotofor for isoelectric 
focusing. Twenty fractions were collected from the Rotofor and their pH 
values determined (Fig. 3). Propionicin PLG-1 activity (32 AU/ml) was found 
in a single fraction, centering at approximately pH 9.1. The specific activity 
was approximately 5700-fold higher than that of the culture supernatant (Table 
1). 
SDS-PAGE. Propionicin PLG-1 preparations at various stages of 
purification were analyzed in 18% tube SDS-PAGE gels (Fig. 4). Several 
contaminating proteins were detected in the preparation after ammonium sulfate 
precipation and dialysis. Propionicin preparation eluted from a descending 
carboxylmethyl sepharose column contained fewer proteins, but several 
proteins of both low and high molecular weight were still present. The single 
active fraction obtained after isoelectric focusing yielded in SDS-PAGE a 
single protein band that had an apparent MW of approximately 10,000. 
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Effect of propionicin PLG-1 on sensitive and nonsensitive 
cells. Crude preparations of propionicin PLG-1 were found to adsorb to 
sensitive cells of P5 and to be bactericidal (12). Purified propionicin PLG-1 
obtained after isoelectric focusing was reevaulated for its bactericidal activity 
against indicator strain P5. Viable counts of indicator strain P5 were reduced 
by 99.6% after exposure to purified propionicin, but viable counts of strain 
PI27 were unchanged (Fig. 5). Residual inhibitory activity was not detected 
in the supernatant of preparations mixed with cells of strain P5, but was 
unchanged in preparations mixed with PI27 cells (data not shown). 
Absorbancy of both suspensions were stable throughout the experiment. 
Propionicin PLG-1 seemed to induce cell death without detectable cell lysis of 
the sensitive strain. 
Plasmid involvement. Producer strain P. thoenii harbors a single 
large plasmid (250 kb), designated pLGl (Fig. 5). To isolate the intact large 
plasmid, significant changes had to be made in the plasmid isolation procedure 
of Rehberger (18), as described in Materials and Methods. These changes 
include SDS-NaCl precipitation of denatured chromosomal DNA, PEG 
precipitation of the plasmid, and removal of single-stranded DNA by phenol 
extraction. Efforts were made to determine if the plasmid carried genetic 
determinants responsible for propionicin production (Prp+) and host immunity 
(Imm+) to the bacteriocin. Mutants deficient in propionicin production (Prp") 
and immunity (Imm-) were obtained by acriflavin and NG mutagenesis. The 
percent kill in all experiments was within the range of 90% - 99% kill. When 
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strain PI27 was grown in the presence of 10 |ig/ml acriflavin, 5% of the 
surviving colonies were found to be Prp". After growth of strain P127 with 
200 |ig/ml NG, 1 % of surviving colonies were Prp-. Carbohydrate 
fermentation patterns, gram-stain reaction, pigment production, and growth 
characteristics exhibited by the Prp- mutants were identical to those of the 
parent culture, P. thoenii PI27 (data not shown). All of the Prp- mutants had 
immunity to propionicin PLG-1 except for one mutant that was Prp- Imm-. 
Agarose gel electrophoresis of plasmid DNA isolated from selected 
mutagenized isolates revealed that three Prp-Imm+ isolates contained plasmid 
pLGl, whereas four Prp-Imm+ isolates were cured of pLGl (Fig. 5). The 
single Prp- Imm- mutant that was isolated contained plasmid pLGl. We also 
examined several mutagenized Prp+ isolates. Of these, two Prp+Imm+ isolates 
contained plasmid pLGl, whereas two Prp+Imm+ isolates were cured of 
plasmid pLGl. 
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DISCUSSION 
Tagg et al. (19) described bacteriocin action as a single-hit mechanism, in 
which the bacteriocin adsorbs to, penetrates, and kills sensitive cells in an 
irreversible process. Purified propionicin PLG-1 was found to adsorb to 
sensitive cells of strain P5 and to be bactericidal. Propionicin did not adsorb to 
its producer strain, but the mechanism of resistance is yet to be determined. 
The targets of propionicin PLG-1 activity and its mode of action on sensitive 
cells have not been determined. 
Accumulation of propionicin during stationary phase is characteristic of a 
secondary metabolite. Maximum production of propionicin was observed at 
pH 7.0. Possible factors for poor production of propionicin at pH 6.0, 6.5, 
7.5 and 8.0 include the following; (i) low cell density obtained at pH 8.0, (ii) 
reaction(s) necessary for active propionicin synthesis may be dependent on one 
or more pH-sensitive enzymes, (iii) proteolytic enzymes that cleave the 
bacteriocin may be more active at other pH values. Propionicin PLG-1 
showed many similarities to lactacin B produced by a strain of Lactobacillus 
acidophilus. Both bacteriocins were produced during the early stationary 
growth phase of producer cultures. Both were originally isolated as large-
molecular-weight protein aggregates (1,12). The initial MW estimates were 
150,000 (12) and 100,000 (1) for propionicin PLG-1 and lactacin B, 
respectively. 
Propionicin PLG-1 (MW 10,000) was isolated from contaminating 
proteins by ion-exchange chromatography and isoelectric focusing. Numerous 
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contaminating proteins were removed by applying partially purified bacteriocin 
to a carboxymethyl sepharose column. A single fraction within a peak of 
absorbance contained bacteriocin activity, but was found to contain 
contaminating proteins. The bacteriocin within this fraction was then purified 
to homogeneity by isoelectric focusing. Evidence for homogeneity of 
propionicin PLG-1 was provided by the absence of contaminating proteins on 
a SDS-PAGE electropherogram. 
P. thoenii P127 was shown to harbor a single large plasmid which seems 
not to encode genetic determinants for propionicin PLG-1 production or host 
cell immunity. The wild-type parent, a Prp"Imm- mutant, some Prp+Imm+ 
isolates exposed to mutagens, and some Prp-Imm+ mutants harbored the 
plasmid. In contrast, other Prp-Imm+ and Prp+lmm+ mutants lost the plasmid 
during curing experiments. No Prp+ Imm- isolates were found. This 
phenotype probably would not be viable because loss of the immunity protein 
would allow the bacteriocin to kill the producer cells. Evaluation of the loss or 
presence of an inactive bacteriocin awaits further work. 
If plasmid pLGl does not carry genes for bacteriocin activity and host 
immunity, these genetic detemiinants may be located within the chromosome. 
It is also possible that an unstable or undetected integrated plasmid could be 
responsible for propionicin PLG-1 production. Although bacteriocin 
production is frequently plasmid-associated (19), there is precedent for this 
trait to be found on the chromosome. For example, Joerger and Klaenhammer 
(1986) found that helveticin J production and immunity in Lactobacillus 
helveticus 481 were chromosomally mediated. 
8 3  
No phenotypic changes were detected in isolates that had been cured of 
pLGl. In addition to bacteriocin production and sensitivity, characterisitics 
that were examined include pigment production, growth rates, and 
fermentation of arabinose, fructose, glucose, lactose, maltose, mannose, 
mannitol, rhamnose, starch, sucrose, trehalose and xylose. Thus, plasmid 
pLGl remains cryptic. The Prp"Imm- mutant was phenotypically identical to 
the wild type in all other characteristics. 
Elucidation of the amino acid sequence of propionicin PLG-1 should 
facilitate cloning of the genetic determinants for this bacteriocin. Further 
characterization of propionicin PLG-1 production and its mode of action is 
currently in progress. 
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Figure 1. Growth of P. thoenii PI 27 and production of propionicin 
PLG-1 at constant pH at 32^0 with continuous agitation. Symbols: •, 
absorbance at 600 nm; •, bacteriocin activity (AU/ml) by the well diffusion 
assay 
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Figure 2. Elution of partially purified propionicin PLG-1 from 
carboxylmethyl sepharose equilibrated with 20mM MES, pH 6.5. 
Propionicin PLG-1 was eluted with a linear gradient of 0 to 1 M NaCl in 20 
mM MES, pH 6.5. Fractions (4.5 ml) were collected and propionicin PLG-1 
activity was determined for each by the well diffusion method. Symbols: •, 
absorbance (280 nm); •, propionicin PLG-1 activity (AU/ml); —, linear 
NaCl gradient 
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Figure 3. pH gradient and refractive indices of fractions collected after 
isoelectric focusing. Twenty fractions (1.5 ml) were collected, absorbance 
(280 nm) obtained, and the pH value of each tube was measured. Symbols: 
•, absorbance (280 nm); •, pH 
I 
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P 
o 
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Figure 4. Tube SDS-PAGE of active fractions obtained after various 
steps in the purification of propionicin PLG-1. Gel A : molecular weight 
standards (top to bottom): ovalbumin (MW 43,000), carbonic anhydrase 
(MW 29,000), P-lactoglobulin (MW 18,400), lysozyme (MW 14,300), 
bovine trypsin inhibitor (MW 6,200), a and p insulin (MW 3,000). Gel B: 
active fraction after ammonium sulfate fractionation. Gel C: active protein 
fraction eluted from a carboxymethyl sepharose column. Gel D: purified 
propionicin PLG-1 after isoelectric focusing 
A 
'.V 
D 
Figure 5. Survival of producer strain PI27 and indicator strain P5 after 
incubation at 320C for up to 30 min with purified propionicin (32 AU/ml). 
Points are the average of duplicate plates which did not differ by more than 
+/-10 CFU/ml. Symbols: •, surviving CPU/ml for producer strain PI27; 
O, surviving CFU/ml for indicator strain P5 
CFU/ml 
o 
Figure 6. Agarose gel electrophoresis of plasmid DNA from 
Agrobacterium tumrfaciens A281 (250 kb; Lane E), wild-type P. thoenii 
P127 (Lane A), Prp- Imm+ mutants (Lanes B, D, F, J, K, L, and M), Prp-
Imm- mutant (Lane I) and Prp+Imm+ mutagenized isolates (Lanes C, G, H, 
andN) 
A B C D E F G H I  J  K L M N  
TABLE 1. Purification of propionicin PLG-1 
Purification 
stage 
Volume Propionicin Total Amount of Specific Yield Fold 
(ml) activity propionicin protein activity recovered purification 
(AU/ml)3 activity (mg/ml)  ^ (AU/mg) (%) 
(AU) 
Culture 25(X) 
supernatant 
Ammonium 
sulfate fiactionation 10 
0.83 
50 
2075 
500 
1.29 
0.129 
0.64 
388 
100 
24 606 
Carboxymethyl sepharose 
eluent, pooled, and 
concentrated 
50 250 0.0063 794 12 1241 o 
o 
Isoelectric focusing 32 160 0.0087 3678 5747 
® AU, Arbitrary units determined by the critical dilution method, 
b Protein concentation determined by the method of Lowry (11). 
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CONCLUSIONS AND PROSPECTUS 
Bacteriocins are proteins released by bacteria that prevent the growth of 
other related bacteria. Other criteria for defining bacteriocins are the presence 
of specific bacteriocin receptors on sensitive bacteria, plasmid-bome 
determinants of production and immunity, and narrow range of inhibitory 
activity. The above criteria are generally applicable to the prototype 
bacteriocins such as the colicins; however, a number of gram-positive 
organisms produce bacteriocins that deviate from the original definition of 
bacteriocin (Reeves, 1972; Tagg et al., 1976). For example, some bacteriocins 
produced by gram-positive bacteria have a broad spectrum of activity (Reeves, 
1972; Tagg et al., 1976; Klaenhammer, 1988). 
The inhibitory substance produced by P. thoenii PI27 is a small, heat-
labile protein that we have designated as propionicin PLG-1. It accumulates in 
the culture supernatant during stationary phase of growth, as is characteristic of 
a secondary metabolite. Maximum activity was measured after about 200 h of 
growth at pH 7.0. 
The production of propionicin PLG-1 was evaluted during anaerobic 
growth of PI27 in NLB at controlled pH. Maximum production of 
propionicin PLG-1 was observed at pH 7. Possible factors for poor 
production of propionicin at pH 6.0, 6.5, 7.5 and 8.0 include the following: (i) 
low cell density was obtained at pH 8.0, (ii) reaction(s) necessary for active 
propionicin synthesis may be dependent on one or more pH-sensitive 
enzymes, (iii) proteolytic enzymes that cleave the bacteriocin may be more 
active at other pH values. 
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Crude preparations of bacteriocin applied to a gel filtration column were 
eluted in two peaks of absorbance, each of which contained bacteriocin 
activity. Proteins in these peaks were estimated to have molecular weights of 
approximately 10,000 and greater than 150,000. Propionicin PLG-1 (MW 
10,000) was isolated from contaminating proteins by ion-exchange 
chromatography and isoelectric focusing. Numerous contaminating proteins 
were removed by applying partially purified bacteriocin to a carboxymethyl 
sepharose column. A single fraction within a peak of absorbance contained 
bacteriocin activity, but this fraction was found by SDS-PAGE to contain 
contaminating proteins. The bacteriocin within this fraction was then purified 
to homogeneity by isoelectric focusing. Evidence for homogeneity of 
propionicin PLG-1 was provided by the absence of contaminating proteins in a 
SDS-PAGE. 
Propionicin PLG-1 is active against some but not all of the classical 
Propionibacterium species, some gram-positive organisms, some gram-
negative organisms, and some yeasts and molds. Purified propionicin PLG-1 
was found to be inhibitory against selected propionibacteria, but more 
extensive testing of the spectrum of activity of the purified protein is needed. 
Tagg et al. (1976) described bacteriocin action as a single-hit mechanism, in 
which the bacteriocin adsorbs to, penetrates, and kills sensitive cells in an 
irreversible process. Purified propionicin PLG-1 was found to adsorb to 
sensitive cells of strain P5 and to be bactericidal. Propionicin PLG-1 did not 
adsorb to its producer strain, but tlie mechanism of resistance is yet to be 
determined. The targets of propionicin PLG-1 activity and its mode of action on 
sensitive cells have not been determined. Clearly, further studies of propionicin 
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PLG-1 are required to elucidate mechanisms for antagonism in these important 
dairy organisms. 
P. thoenii P127 was shown to harbor a single large plasmid that seems not 
to encode genetic determinants for propionicin PLG-1 production or host cell 
immunity. The wild-type parent, some Prp+ mutants, and some Prp" mutants 
harbored the plasmid, but in contrast other Prp- and Prp+ mutants lost the 
plasmid during curing experiments. These data suggest that plasmid pLGl is not 
responsible for Prp+ activity and that genetic determinants for bacteriocin 
production and immunity may be located within the chromosome. Until 
propionicin and immunity genes are located on the chromosome, a possibility 
exists that an unstable or undetected integrated plasmid could be responsible for 
propionicin PLG-1 production. Joerger and Klaenhammer (1986) found that 
helveticin J production and immunity in Lactobacillus helveticus 481 were 
chromosomally mediated. Similar observations were reported for lactacin B 
(Barefoot and Klaenhammer, 1983) and lactocin 27 (Upreti and Hindsdill, 
1975). Prp-Imm+ mutants cured of plasmid pLGl were phenotypically identical 
to plasmid-bearing PrpTmm+ mutants and the parent strain PI27 in fermentation 
patterns, growth rates, and immunity spectra. 
In the future, attempts should be made to clone the bacteriocin gene(s) into 
E. coli by a shotgun cloning procedure. Once the bacteriocin gene(s) are cloned 
into an appropiate vector and characterized, the vector could be moved into a 
strain of Propionibacterium that carries other desirable traits, such as high 
propionic acid production or good growth in natural environments. However, 
transfer and maintenance of a stable independent plasmid in a Propionibacterium 
recipient have not been seen. Further work is needed in the development and 
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construction of vectors that can be maintained autonomously in propionibacteria. 
The use of bacteriocin genes in strategies for future strain improvement also 
awaits development of effective gene transfer systems in propionibacteria. The 
introduction of bacteriocin genes into a high-acid-producing strain would be 
useful for development of an inoculum for preservation of silage and high-
moisture grains during storage, because primary spoilage organisms in these 
systems are yeasts and molds. 
The recent approval by the FDA of nisin as an additive to cheese spread has 
set a precedent for use of bacteriocins in food products in the United States 
(Benkerroum and Sandine, 1988; Ogden, 1986; Spelhaug and Harlander, 
1989). Microgard, a grade A skim milk preparation fermented by 
Propionibacterium shermanii, can prolong tlie shelf life of cottage cheese to 
which it has been added (Al-Zoreky, 1988; Daeschel, 1988). Propionicin PLG-
1 is different from Microgard, which contains an inhibitory substance of low 
molecular weight. Microgard inhibits many gram-negative organisms, some 
molds and yeasts, but no gram-positive organisms. 
Preliminary studies have indicated that propionicin PLG-1 inhibits some 
gram-positive bacteria including some but not all species of propionibacteria, 
some gram-negative bacteria including Pseudomonas spp., and some yeasts and 
molds. The inhibitory action of this bacteriocin should be investigated in yogurt 
and cottage cheese both alone and in combination with Microgard and nisin. 
Typical spoilage organisms (e.g. Pseudomonas) or food-bome pathogens can 
be added to challenge the natural preservatives. Optimal conditions for 
production of propionicin PLG-1 in large-scale liquid culture, including best 
growth medium for bacteriocin production. 
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need to be determined. Methods for producing stable, high-titer bacteriocin 
preparations are also needed. 
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APPENDIX 
Gram-positive strains inhibited by strain F127 using the agar spot assay 
Organism Growth conditions Zone of inhibition^ 
Bacillus cereus BHI, 350c -
Bacillus globiqii BHI, 350c -
Bacillus macerans BHI, 350c -
Bacillus megaterium BHI, 350c -
Bacillus polymyxa BHI, 350c -
Bacillus subtilis BHI, 350c -
Clostridium perjringens BHI, 370c -
Clostridium sporogenes BHI, 370c -
Lactobacillus bulgaricus AR2 MRS, 370c +2 
Lactobacillus casei MRS, 370c +2 
Lactococcus lactis subsp. cremoris APT, 370c +2 
Lactococcus lactis ^uh^T^.diacetylactis APT, 370c +2 
Lactococcus lactis subsp. lactis APT, 37oC +3 
Listeria monocytogenes Scott A BHI, 35oC -
Pediococcus cerevisiae MRS, 320C +2 
Staphylococcus aureus BHI, 370c -
Streptococcus faecalis BHI, 370c -
^ Diameter of the zone of inhibition: - no inhibition; +1, < 10 mm; +2,11-
14 mm; +3,15-17 mm; +4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
1 2 5  
Gram-negative strains inhibited by strain PI27 using the agar spot assay 
Organism Growth conditions Zone of inhibition^ 
Aeromonas hydrophilia 
Campylobacter jejuni 
Escherichia coli JM109 
Escherichia coli V517 
Pseudomonas fluorescens 
Pseudomonas aeruginosa 
Salmonella enteritidis 
Salmonella typhimurium 
Vibrio parahaemolyticus 
Yersinia enterocolitica 
BHI, 370c 
Thioglycollate, 370C +2 
TSB, 370c +lb 
TSB, 370c +lb 
BHI, 370c +4 
BHI, 370c +4 
BHI, 370c 
BHI, 370c 
BHI, 320C +3 
BHI, 370c 
^ Diameter of the zone of inhibition: - no inhibition; +1, < 10 mm; +2,11-
14 mm; +3,15-17 mm; +4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
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Yeast and mold strains inhibited by partially purified bacteriocin from strain 
PI27 using the well diffusion assay 
Organism Growth conditions Zone of inhibition^ 
Aspergillus wentii ATCC 1778 Czapek Dox, 32^C +2 
Apiotrichum curvatum Czapek Dox, 32^0 +1 
Candida utilis Czapek Dox, 320C +3 
Candida lipolytica Czapek Dox, 320C +1^ 
Fusarium tricinctum Czapek Dox, 320C +1 
Pencillium chrysogenum Czapek Dox, 320C 
Phialophora gregata Czapek Dox, 320C +3 
Saccharomyces cerevesiae ATCC 24702 TSB, 320C +1^ 
Saccharomyces cerevesiae TSB, 320C +1^ 
Saccharomycopsis fibuligera Czapek Dox, 320C +3 
Scopulariopsis sp. Czapek Dox, 320C +3 
Trichoderma reesi Czapek Dox, 320C +3 
^ Diameter of the zone of inhibition : - no inhibition; +1, < 10 mm; +2,11-
14 mm; +3,15-17 mm; +4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
1 2 7  
Propionibacteria strains inhibited by strain PI27 using the agar spot assay 
Organism Strains tested Zone of inhibition^ 
P. acidipropionici P2 +4 
P3 +4 
P5 +4 
P68 +2b 
P83 +4 
P88 +4 
P. jensenii P34 +4 
P54 +4 
P63 +4 
P74 +4 
P108 +1 
^ Diameter of the zone of inhibition ; - no inhibition; +1, < 10 mm; +2,11-
14 mm; +3,15-17 mm; +4, > 18 mm. 
b Zone of inhibition was hazy, not clear. 
1 2 8  
Propionibacteria tested for sensitivity to propionicin PLG-1 
Organism 
P. freudenreichii subsp. jreudenreichii 
Strains tested: P22, P32, P33, P45, P62, and PI 13 
Zone of inhibition: no inhibition 
P. freudenreichii subsp. shermanii 
Strains tested: P18, PI9, P35, P48, P49, P77, P80, P93, PI 15, and PUB 
Zone of inhibition: no inhibition 
P. thoenii 
Strains tested: P4, P15, P20, P38, and P85 
Zone of inhibition: no inhibition 
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Summary of characteristics of propionicin PLG-1 
pH stability 
isoelectric point 
production 
spectrum of activity 
heat stability 
molecular weight 
sensitivity to 
various enzymes 
mode of action 
immunity and 
adsorption 
Stable over a wide pH range (3-9) 
Approximately 9.0 
Extracellular product with maximum 
production at pH 7.0 
Active against some but not all classical 
Propionibacterium species, some gram-
positive organisms, some gram-negative 
bacteria, and some yeasts and molds. 
Stable up to 850C, but loses stability at 
90OC. 
Protein of apparent molecular weight of 
10,000 
Sensitive to many proteolytic enzymes 
Single-hit mechanism which is 
bactericidal but not bacteriolytic. 
Target site is unknown. 
Producer strain PI27 is immune to 
propionicin PLG-1 and does not 
appear to adsorb the bacteriocin 

